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Abstract 
Endurance performance at altitude is diminished as a consequence of the hypoxic 
environment.  Timing the arrival at altitude prior to such a competition is an important 
consideration due to time-dependent changes as a result of acclimatization.  While the time 
course of changes over the first few weeks of altitude exposure has been well documented, the 
changes seen within the first few hours of arrival have not been characterized.  As a result, 
coaches and athletes employ varied arrival strategies in an attempt to maximize performance, 
notable arrival just prior to the competition or arrival the night before competition. 
Purpose:  To compare cycling 20km time trial performance outcomes and related parameters 
at altitude after 2 hours and 14 hours of arrival at a simulated altitude of 2500m. 
Methods:  Subjects performed a familiarization 20km time trial, followed every 7 days by a 
total of 3 overnight stays in an altitude tent.  The three random, single-blinded interventions 
were as follows: 14 hours of hypoxia, 12 hours of normoxia and 2 hours of hypoxia, or 14 
hours of normoxia.  The two hypoxic trials were followed by a 20km time trial in hypoxia and 
the normoxic trial was followed by a 20km time trial in normoxia.  Ventilatory 
acclimatization, sleep disturbances, and plasma volume decrements were also measured 
during the study. 
Results:  No differences were observed in performance times between the two hypoxic trials.  
Average times to completion for each trial were: 2hr - 36:47 ± 0:47s, 14hr – 36:44 ± 0:50s, 
CTRL – 35:34 ± 0:39s.  After 14 hours, plasma volume decreased by an average of 235 ml 
more than control, while an additional decrease over control of only 22ml occurred during the 
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2hr trial.  V̇E/ V̇O2 values for each subsequent 4km were as follows: 34.4 ± 7.0, 33.4 ± 5.1, 
33.8 ± 5.5, 32.9 ± 4.4, 35.9 ± 5.4 for the 2hr trial and 32.3 ± 6.1, 32.2 ± 5.8, 32.7 ± 5.3, 32.4 ± 
5.2, 34.9 ± 5.6 for the 14hr trial, respectively (n.s. at any time point).  Activity counts during 
sleep were 744.7 ± 30.2 for the 2hr trial and 740.9 ± 31.7 for the 14hr trial (n.s.). 
 Conclusion:  Differences in endurance exercise performance are not observed at altitude 
during the first 14 hours of arrival at altitude.  While the some of the variables that would be 
expected to alter performance did show changes within this time frame (e.g. plasma volume 
loss), they were either not substantial enough to alter performance or acted to counter-balance 
each other, leaving performance variables equally affected by acute altitude exposure. 
 
 
 
 
Chapter 1 
 
Introduction 
 The 1968 Olympic Games in Mexico City were marked by the detrimental effects of 
the moderate altitude (2420 m) on the performance of endurance athletes.1  Although it had 
been previously established that performance of endurance athletes at high altitude is 
diminished as a consequence of the hypoxic ambient environment, this obstacle became 
abundantly clear even at moderate altitudes.  As a result, acclimatization strategies became 
vital for athletes competing at moderate elevations in order to minimize the performance 
decrements.  The goal of these strategies was primarily to affect adaptations that improved 
oxygen utilization and delivery.  Two disparate reasons for altitude acclimatization became 
evident: those who trained at altitude to improve sea level performance and those who tried to 
maximize performance at altitude.  While athletes training at altitude are concerned with the 
long-term benefits of altitude residence, athletes who are simply competing at altitude are 
typically only concerned with maximizing their performance during the specified competition.  
This study aims to address the arrival strategies of those athletes competing at altitude. 
Arrival at competition altitude at least 14 days prior to the event is the current 
predominant best-practice recommendation for acclimatization to moderate altitudes for 
endurance performance purposes.2  It is believed that two weeks of hypoxic exposure allow 
for adequate ventilatory acclimatization and for performance measures to return as closely as 
possible to sea level values.  After two weeks of altitude residence many of the short term 
acclimatization effects, such as peripheral chemoreceptor mediated increases in ventilation, 
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are nearing completion.  This time frame also precedes the detrimental training effects 
associated with prolonged exercise in hypoxia.  The hypoxic ventilatory response has been 
shown to increase over time after the initial exposure to altitude, which suggests that as close 
to two weeks of altitude exposure is preferable.  However, this time frame is often impossible 
for team sport athletes or athletes on strict travel schedules for whom arriving at the place of 
competition two weeks prior is unrealistic.  Obviously these later arriving athletes will 
experience inadequate acclimatization effects which mitigate performance decline at altitude 
than those athletes who can appropriately acclimatize.  For the athletes arriving shortly before 
competition, a short-term arrival strategy is necessary, although this has not been adequately 
investigated. 
 For athletes who logistically can only arrive within a day or two of an altitude 
competition, there are two primary arrival strategies commonly used with the hope that 
performance decrements at altitude will be modulated.  Most commonly, athletes will arrive at 
a “typical” time of the day before the competition.  It is proposed that in arriving the day prior 
may hold advantages over arriving the morning of the competition, as any extra time at 
altitude is beneficial in ventilatory acclimatization that in turn helps maintain oxygen (O2) 
saturation in the blood.3  However, the increased ventilatory rate also leads to an excessive 
carbon dioxide (CO2) washout and subsequent alkalosis, which eliminates the normal 
hyperventilatory stimulus. This may in turn lead to intermittent breathing, especially at night, 
impairing sleep quality before competition.4  Additionally, the extra hours at altitude will 
likely cause acute plasma volume loss, which might be mitigated with a shorter term arrival at 
altitude.  As a result, an alternative strategy that is gaining use in the athletic community is to 
arrive as close as possible to the start time of the altitude competition (aka a “fly in, fly out” 
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strategy), with the hope that any acute negative effects of altitude exposure are minimized.5,6  
Currently, there are no data examining the potential effects of short term (e.g. 2 hours vs. 14 
hours) of acute altitude exposure on performance at altitude.   
 
Purpose 
 The purpose of this study is to assess the differences in endurance performance of 
short-term arrival strategies for competitions at moderate altitudes.  We also investigate the 
changes in sleep quality, ventilatory acclimatization, and plasma volume of athletes sleeping 
at altitude and at sea-level and their relation to performance differences.  We attempt to 
reconcile the disparate consequences of altitude residence to find the optimal time frame that 
was 16 hours or less for arrival at altitude.  Knowledge of the acute effects of altitude 
exposure in this time frame will help endurance athletes bound by short-term arrival logistics 
to adequately prepare for competitions at moderate altitudes. 
 
Justification for the Study 
 The timing of arrival for optimal altitude performance has been well studied in the 
literature.  While some earlier studies did not show improvements in performance with 
acclimatization,7,8 more recent studies have, likely due to controls for altitude sickness, iron 
stores, and detraining (“live-high, train-low”).2,9-12  Scientists, coaches and athletes generally 
agree that around 14 days of continuous hypoxic exposure is sufficient for proper 
acclimatization at moderate altitudes.  Yet, the literature on adaptive responses and 
performance at altitude over shorter periods of time is insufficient. One of the few studies that 
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considered this issue, Weston et al. (2001) found that the detrimental effects of altitude were 
lower among athletes after 18 or 47 hours of arrival at an elevation of 1700 meters than they 
were at 6 hours after arrival.3  While this study seems to indicate that longer altitude residence 
is most beneficial, the subjects (youth rugby players) performed a shuttle run test and repeated 
push up test, which are not objective measures of endurance performance.  Our study will 
employ a time trial for a distance that our subjects (elite cyclists) are accustomed to 
completing (20-km). 
As a result of the acute exposure times of this study, the changes most likely to affect 
performance include ventilatory acclimatization, decreases in plasma volume, and disruptions 
during sleep.  Altitude residence has been shown to enhance erythropoiesis after a period of 
time, as long as iron intake is sufficient,13-15 but this adaptation is not likely be significant over 
the course of the acute altitude exposure in this study.16 It is understood that ventilatory 
adaptations begin to occur soon after arrival at altitude,17 but it takes up to two weeks to revert 
to near sea-level values for many performance variables.2  It has also been shown that sleep 
quality is decreased at altitude.4  Seemingly, an overnight stay at altitude would benefit 
ventilatory acclimatization, and O2 delivery and utilization which would improve performance 
but may also would also result in more restless sleep which would hinder performance.  
Plasma volume decreases at altitude as a result of dehydration, diuresis, increased capillary 
hydrostatic pressures, and plasma protein loss.18,19  This drop likely impairs cardiac function, 
decreasing the ability of the blood to deliver oxygen to the periphery, and limiting endurance 
performance.  The time courses of the effects of these three variables need to be outlined to 
understand the best acute altitude arrival strategies. 
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 With the growing popularity of higher altitude competitions, such as trail and ultra-
marathon running, a thorough analysis of short-term arrival strategies is becoming 
increasingly essential.  Coaches and athletes will be able to determine which arrival strategies 
result in the best possible performance outcomes.  In the present study, an effort was made to 
determine which of the predominant arrival strategies (i.e. evening prior or morning of 
competition) was most effective at minimizing performance decrements from sea level values. 
Delimitations 
 The study was delimited to the following: 
1. Ten male elite endurance athletes, between the ages of eighteen and thirty, with a 
minimum V̇O2max of 55 ml/min/kg on a cycle ergometer.   
2. A total of five visits to the lab: a preliminary V̇O2max test, a familiarization trial, 
and 3 blinded trials including sleeping and performing at altitude, sleeping at sea 
level and performing at altitude, and sleeping and performing at sea level. 
3. The use of a hypoxic tent to simulate the hypoxic environment of an elevation of 
2,500 m.  
4. The use of wrist activity monitors to measure wakefulness during sleep trials. 
5. Pre-exercise measures of sleep quality and arterial saturation, pre-sleep and post 
exercise measures of hemoglobin mass (via carbon monoxide (CO) rebreathing), 
hemoglobin concentration, hematocrit, arterial oxygen saturation, and body 
weight. 
6. Measures of performance times for 20 km time trial, power output, V̇E, V̇O2, SaO2, 
RER, heart rate, RPE, end tidal partial pressures, and dyspnea during time trials. 
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7. A data collection period throughout the fall and spring semesters of the 2013-2014 
school year. 
 
Limitations 
 The following limitations were acknowledged with this study: 
1. The sample size was relatively small (n=10) given the required number of trials. 
2. Physical activities between trials was recommended to fit a particular criteria but 
not controlled. 
3. The use of an artificial normobaric hypoxic tent may have different physiological 
outcomes than the hypobaric hypoxic environment found at true altitude.  Use of 
normobaric hypoxia during the performance trial may have different outcomes 
versus the hypobaric hypoxic environment found at altitude. 
 
Assumptions 
 The study was based on the following assumptions: 
1. The physiological adaptations at normobaric hypoxia and hypobaric hypoxia are 
similar enough for the findings in this study to be relevant. 
2. The subjects in this study will have similar adaptive reactions to the hypoxic 
environment. 
3. The subjects will have equal motivation to perform at their best in all performance 
trials. 
7 
 
4. The self-reporting of the subjects on questionnaires and ratings scales were 
representative of the actual experiences and effort levels encountered. 
5. The subjects followed the investigator’s requests to utilize similar routines 
between each trial. 
6. CO rebreathing is a valid method of measuring hemoglobin mass and calculating 
plasma volume. 
7. Subjects will not be exposed to any ambient air at any point during the hypoxic 
portion of the trials. 
Hypotheses 
 The study was designed to test the following null hypotheses: 
1. There is no difference between performance trials of an overnight stay of at least 
14 hours at a simulated altitude or an arrival only 2 hours before the simulated 
altitude trial. 
2. There is no difference in sleep quality during the overnight stay and the night 
preceding the 2 hour pre-trial arrival. 
3. There is no relationship between the amount of time spent at altitude and the 
concentration of hemoglobin in the blood, the hematocrit, or the plasma volume of 
the subjects 
4. There is no relationship between 2 or 14 hours of hypoxic exposure on the average 
power output during the time trial. 
5. There will be no difference in perceived effort (RPE) during the altitude and sea 
level trials. 
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6. There will be no difference in ventilatory measures, such as frequency of 
breathing, V̇E, V̇O2, RER, and dyspnea between the overnight stay and the 2 hour 
pre-trial arrival. 
Definition of Terms 
 The following terms are defined to clarify their use in this study: 
 Acclimatization: Physiological adaptations in response to altitude residence, such as 
central and peripheral changes that improve oxygen delivery and utilization.17 
Arterial oxygen saturation (SaO2):  The ratio of oxyhemoglobin to the total amount of 
hemoglobin present in the blood.20 
Elite endurance athletes: Individuals who train regularly for competition and have a 
V̇O2max of 55 ml/min/kg or higher. 
Expired ventilatory volume (V̇E):  The volume of air expired per minute of time by the 
subject (in L/min).21 
Hypoxemia: Deficient oxygenation of the arterial blood22 
Hypoxia: Decreased partial pressure of O2 in the ambient environment compared to 
sea level values.23 
 Moderate altitude: Elevations of 2000 m – 3000 m (as defined by Bartsch et al. 
2008)24  
 Oxygen Consumption (V̇O2): The volume of oxygen consumed by the body per 1 
minute of time (in ml/min).25  
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Short-term arrival strategies: Methods for maximizing athletic performance in 
endurance events at altitude when time frame for arrival at altitude is limited to 2-14 hours. 
 Sleep quality: a measure of the adequacy of sleep dependent on the number of 
awakenings and disruptions throughout the night. 
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Chapter 2 
Review of the Related Literature 
 
Introduction 
 The physiological adaptations to acute and chronic hypoxia and the resultant effects on 
exercise performance have been extensively studied. The time course, extent, and factors 
controlling multiple variables related to altitude acclimatization will interact to ultimately 
influence exercise performance at altitude.  While altitude acclimatization effects have been 
generally described, the specific time course and magnitude of altitude-mediated performance 
declines with varying lengths of acute altitude exposure have not been well characterized. 
 The literature related to the timing of arrival for endurance competitions at moderate 
altitude is reviewed in this chapter.  We hypothesize that with differing lengths of acute 
altitude exposure, the primary physiologic variables which will influence differences in 
endurance exercise performance at altitude are magnitude of ventilatory acclimatization, 
magnitude of plasma volume loss, and differences in sleep quality.  Therefore, the review of 
the extensive literature on altitude acclimatization effects and exercise performance at altitude 
has been limited and focused on selected topics and presented in the following order: (a) 
Effects of Acute Exposure to Hypoxia on Performance, (b) Ventilatory Acclimatization to 
Altitude, (c) Effects of Acute Altitude Residence on Plasma Volume, (d) Effects of Acute 
Altitude Residence on Sleep Quality and (e) Summary.  
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Effects of Acute Hypoxia on Performance 
 Oxygen transport and delivery directly relates to the amount of work that can be 
produced by human skeletal muscle. This system, the oxygen transport pathway as Weibel 
(1984) described it, involves alternating steps of diffusion and perfusion to transport O2 to the 
periphery to allow for the muscles to produce work.26  A four-step process allows for the 
delivery of O2 from the ambient air into the mitochondria in the working muscles. The first 
step is the translation or convection of ambient air to the alveoli. Second, the O2 diffuses 
across the alveolar-capillary barrier and binds reversibly to hemoglobin. In the third step, the 
flow of blood through the arteries transports the oxygenated hemoglobin to the periphery and 
ultimately the capillaries in the tissue. The final step consists of the diffusion of the O2 across 
the blood-gas barrier and into the mitochondria, where it is utilized in the electron transport 
chain to generate adenosine triphosphate (ATP).  Oxygen transport is one of the major 
determinants of performance in normoxic conditions.27 Therefore, this process is a critical 
limiting factor under hypoxic conditions.  In hypoxia, there are fewer oxygen molecules 
transported to the alveoli for each breath taken.  This means that while breathing normally, 
fewer molecules can diffuse into the blood, be transported to the periphery, and be unloaded 
in the working muscle. Training has been shown to increase blood volume, including both 
erythrocyte and plasma volume enhancements, which would help to minimize the delivery 
limitations.28  However, for acute altitude exposures, this adaptation will not occur. 
It has long been known that acute endurance performance is inhibited at moderate and 
high altitudes and that maximum aerobic capacity is impaired.8,29-31  The extent of the 
impairment depends primarily on the magnitude of the elevation, which directly affects the 
partial pressure of ambient oxygen (PiO2). The lower partial pressure of ambient O2 results in 
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a lower partial pressure of O2 in the lungs. The binding of O2 to hemoglobin is driven by a 
higher partial pressure in the alveoli than the partial pressure in the blood. Consequently, the 
lower partial pressure in the lung diminishes the saturation of O2 in the blood. This means that 
the blood carries fewer molecules of O2 per unit of volume than it does under normoxic 
conditions.  The functional consequence of these conditions is that O2 availability and 
delivery to the working muscles would be lower if other physiological variables remained 
unchanged.  There would be fewer molecules of O2 available for the mitochondria to exploit 
in the process of oxidative phosphorylation.  In response, cardiac output must be increased to 
meet the metabolic demand during submaximal exercise.  During maximal exercise, less 
oxygen can be delivered to the periphery and thus oxidative phosphorylation is diminished.  
The disruption of aerobic energy production results in a faster onset of metabolic 
disturbances, such as acidosis, accumulation of inorganic phosphate, and intracellular 
potassium disruption, and ultimately a more rapid decline into exercise failure.32-34 
 A slew of studies came out on the topic of performance and adaptation at altitude in 
the late 1960s in response to the upcoming 1968 Olympic Games in Mexico City, which 
confirmed the limiting nature of low oxygen availability.  Dill (1966) claimed to produce the 
first systematic study of maximal exercise in acute exposures to low barometric pressures, and 
was one of the few studies that measured performance.35  In this study, the authors 
participated as the subjects and were given exposure to the hypobaric environment for around 
30 minutes or less.  The authors compared this data with data from two previous studies on 
Dill (1962) and Dill and Phillips (1964), which involved exposure time of 2 days and 8 days 
respectively.36  The percentage drop in performance for Dill and Phillips in the 1962 study 
was considerably higher than after an 8-day exposure in the 1964 study.  However, Dill 
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managed to maintain 89% of sea-level performance after 2 days at 535mmHg in 1962 and 
88% of sea-level performance after 30 minutes exposure in 1965.  Balke (1965) found 
approximately 6% decrease in maximal oxygen uptake two to three days after arrival at 
2,800m.29  This was despite a substantial rise in pulmonary ventilation in response to the 
hypoxia.  Buskirk (1967) found that V̇O2max decrements follows a fairly linear trend with 
increasing altitude.30  This study found no improvement in aerobic capacity with continued 
training at altitude. Hansen (1967) showed similar decreases in V̇O2max in soldiers, but also 
found that the rate of ascension had no effect on the magnitude of the reduction. The author 
notes that when the PiO2 dropped from 150 to 85 mmHg, the V̇O2max of the subjects was 
maintained at 83% of sea-level values.37  This suggests that an increase in ventilation allowed 
the subjects to maintain a higher than expected V̇O2 at this elevation, albeit still considerably 
lower than sea-level values.  More recent studies have looked at the factors that affect 
V̇O2max decline with acute altitude exposure.38-45  A paper by Wehrlin and Hallen (2006) 
nicely compiled the data from a number of these studies that show the reduction in V̇O2max 
associated with the magnitude of the altitude exposure (Fig. 1).46  After reviewing this data – 
all in highly endurance athletes - it is clear that V̇O2max is significantly impaired at moderate 
and high altitudes during acute exposures.  
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Figure 1. Comparison of V̇O2max reduction and altitude             
 
 
Fig. 1 - Percent decrease in V̇O2max from sea level values. ‘‘Sea level’’ in these studies is set at 0 m 
but varies originally from 0 to 362 m. (Wehrlin and Hallen, 2006) 
 
It is often argued that V̇O2max decline at altitude has a strong correlation to 
decrements in exercise performance at altitude, but there are little data to support this claim.  
To address this issue, Chapman et al. (2011) studied the relationship between arterial 
oxyhemoglobin saturation (SaO2), V̇O2 during treadmill running at 3000m race pace, and 
3000m running performance of elite runners.47  The investigators in this study found that the 
extent of the performance decline at altitude (2100m) was significantly related to the drop in 
SaO2 and oxygen uptake between normoxia and hypoxia (17.1% O2, equivalent to 2100m).  
Since significant correlations have already been shown between SaO2 reduction and V̇O2max 
impairment,38,39,48 one can transitively assume that V̇O2max decrements and performance 
impairments would also be strongly correlated.  Other studies have shown that maximal 
exercise performance is impaired significantly during acute altitude exposures.  Gore (1997) 
showed that even an elevation of 580m has been shown to reduce 5-minute cycle ergometer 
power output by 5.9%.40  A study by Brosnan showed that female cyclists selected power 
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outputs that were 5-6% below normal values while breathing hypoxic gas.49  The performance 
decrements at moderate altitude are perhaps best shown in a study by Clark et al. (2007), in 
which V̇O2peak and 5-min time trial mean power output are compared for increasing 
elevations.  The researchers found that the mean power output and V̇O2peak at even 1,200m 
was significantly lower than at 200m of altitude.  With the drastically negative effects of 
hypoxia on endurance performance, it is obvious that maximizing performance by properly 
acclimatizing to altitude is vitally important for competitive athletes.   
The often-suggested “best practice” for maximizing performance at altitude is to arrive 
at the competition elevation about 14 days prior to the day of the competition.  Schuler et al. 
showed that cycling performance at altitude was significantly improved after 14 days at 
altitude when compared to performances after 1 day and 7 days of exposure.2  Also, note that 
performance did not significantly improve with additional residence at altitude out to 21 days. 
Figure 2.  
                  
Figure 2.  Individual and mean values for c) time to exhaustion at sea level (SL) and on Days 
1–21 (Days 1, 7, 14, 21, respectively) of acclimatization. aP<0.05 compared with SL; bP<0.05 compared 
with, e.g. Days 7–1, Days 14–7 and Days 21–14. 
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A helpful review by Fulco (1998) showed that the magnitude of submaximal exercise 
performance decrement is proportional to both elevation and the duration of altitude 
residence.50  Another finding from this study showed that submaximal exercise performance 
can return to sea level values with increasing duration of altitude residence, without any 
improvements in V̇O2max.  A residence period of 14 days allows for the athlete to properly 
acclimatize without experiencing the substantial detraining effects that can occur with long-
term exposure to hypoxia.6  However, given that not all athletes can arrange travel plans 
around this time frame, the question of the time course of performance shortly after exposure 
to altitude becomes relevant.  Short-term variations in these performances have not been 
shown, with the exception of the Weston et al. (2001) study (Figure 3).3   
Figure 3. 
                   
These researchers showed that performance decrements were greater at 6 hours after 
arrival than 18 or 47 hours after arrival.  They showed that heart rate was greater after 6 hours 
at altitude for a given submaximal workload than it was at sea-level.  They also showed that 
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time to completion on a shuttle run test was greatest after 6 hours of altitude exposure than at 
sea-level, after 18 hours of exposure, or after 47 hours of exposure.  However, there are some 
concerns with the design of this study, including the use of non-elite athletes and the team 
nature of the subject cohort (high school rugby players), and the implementation of a shuttle 
run test and repeated push-up test to measure performance.  Specific to the question of 
endurance athletic performance, it would be considerably more relevant to study the time 
course of performance changes during acute altitude exposure by using elite cyclists or 
runners and measuring time trial performance for moderate to longer distances.  Further 
investigation into the time course of these physiological and performance changes shortly 
after arrival at altitude is needed.   
18 
 
Ventilatory Acclimatization to Acute Moderate Altitude 
 In order to effectively minimize the performance decrements at altitude, the time 
course of the limiting variables and their contribution to the performance limitation must be 
well understood.  As discussed earlier, oxygen transport and delivery is one of the primary 
limiting variables in endurance performance at altitude.   In response to this, the rate of 
ventilation has been shown to increase - a response that occurs almost immediately with 
exposure to hypoxia.  In order to maintain a similar supply of oxygen as at sea-level, a greater 
volume of air must be ventilated to accommodate the decrease in number of oxygen 
molecules with each breath.  Peripheral chemoreceptors in the carotid bodies detect a low 
partial pressure of oxygen in the blood and neural mechanisms are activated to increase the 
rate of breathing.51  This increase in ventilation at altitude has been termed the hypoxic 
ventilatory response (HVR). 
The realization that ventilation increases at altitude is not a new concept.  Rahn and 
Otis (1949) observed that while both an acclimatized and unacclimatized subject saw 
increases in ventilation at altitude, the acclimatized subject had a greater increase than the 
unacclimatized subject in HVR.17  This indicates that the gain in the ventilatory response to 
hypoxia increases with duration of hypoxic exposure.  Smith (1986) showed the time course 
of the ventilatory response in stationary goats.52  Data from this study showed that arterial 
PCO2 dropped until around 8 hours after exposure, after which it appeared to level off.  HVR 
is controlled by several physiological mechanisms, some of which can last long enough to 
affect future hypoxic exposures, and some of which only last for a few seconds.53 
The primary mechanism of the HVR is a substantial and complicated process, as 
outlined by Teppema (2009) in an extensive review.54  The initiating step in this mechanism is 
19 
 
the sensation of low PO2 in the blood stream by the carotid bodies located in the carotid 
arteries.  In addition to pressure these complex organs are sensitive to acidosis, hyperkalemia, 
hypercapnia, hyperthermia, circulating hormones, hyposmality, hypoglycemia, and 
pharmacological agents.55,56  In hypoxia, oxygen sensors inhibit potassium channels in the cell 
membranes of the carotid body, resulting in increased intracellular calcium [Ca2+].57-61  
Neurotransmitters are then released which act on the afferent carotid sinus nerves and signal 
the O2 decrease to the brain.57  There does seem to be a general consensus that the 
neurotransmitters responsible for exciting these afferent nerve endings are acetylcholine and 
ATP.62-66  The nerve conduction signal reaches the brain which in turn initiates the increased 
contraction frequency of the inspiratory muscles. 
The HVR begins almost immediately after the onset of hypoxic exposure and then 
becomes slightly more pronounced throughout the first week of the sojourn.67  Initially, this 
increased ventilation leads to a decreased arterial partial pressure of CO2 and respiratory 
alkalosis.  However, at altitudes below 3,000m this phenomenon appears to be alleviated 
within the first few days, partially by an increased urinary excretion of sodium.68,69  Plasma 
aldosterone levels are reduced as a result of the expulsion of sodium.70  A paper by Townsend 
(2002) showed the time course of changes in HVR response as a result of a “Live High Train 
Low” protocol.71  HVR was shown to increase for the first 15 days of exposure to hypoxia.  
Some studies have also shown that ventilation continues to be gradually increased for the first 
few days at altitude, suggesting an increased sensitivity to the low partial pressure of O2 and 
subsequent increased HVR.72,73  However, none of these studies look at the time course of 
changes to HVR for the first 24 hours of altitude residence. 
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The increase in ventilation is not limited to resting conditions, but is also observed 
during maximal and submaximal exercise.7,37  The hyperventilation increases alveolar PO2 
nearer to sea-level values, which in turn minimizes arterial oxygen desaturation.74  The 
prevention of arterial oxygen desaturation inhibits the reduction of V̇O2max.  From this, one 
can presume that the hypoxic ventilatory response acts to modulate performance decrements 
at altitude. 
 Despite the potential for improved oxygen delivery and improved performance as a 
result of the increased ventilation at altitude, there are several complications that accompany 
this adaptation.  The first of these is that increased respiration due to a larger tidal volume 
leads to greater respiratory water loss.75  In response, an athlete must drink enough water to 
replace what will be lost. This could be problematic during long aerobic exercise, when the 
gastric emptying rate may be exceeded by hemoconcentration due to sweating and changes in 
oncotic pressure due to an accumulation of proteins in the interstitial fluid.  It is generally 
assumed that gastric emptying rate can be a limitation to hydration status, although this has 
not been shown in the literature.   Another potential problem is that the increased ventilation 
comes at the cost of greater respiratory muscle work.  As well as possible fatigue of the 
respiratory muscles, the increased work of breathing has been shown to be detrimental to 
performance by reducing leg oxygen uptake during maximal exercise.76  The vasoconstriction 
at this exercise intensity affects cardiovascular adjustment of blood flow away from the 
skeletal muscle to ensure oxygenation in the respiratory muscles.77  This has not been shown 
in submaximal exercise.78 
 In conclusion, we expect the HVR to increase throughout the first 14 hours of 
exposure to hypoxia.  We expect the ventilatory acclimatization to affect an increase in V̇E, 
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SaO2, V̇O2max, and performance, all other variables being unchanged. This effect will likely 
be greater after 14 hours of exposure than it would after only 2 hours of exposure. 
 
Effects of Acute Altitude Residence on Plasma Volume 
 Within 24 hours of arrival at natural altitude, hemoglobin concentration [Hb] and 
hematocrit (Hct) start to rise.  This is sometimes mistakenly attributed to an increase in the 
total number of red blood cells (RBCs) in circulation.  However, this is not physiologically 
possible, as a significant increase in erythropoietin would still only lead to an increase in 
young red blood cells after a number of days.  Rather plasma volume is decreased with acute 
exposure to moderate and high altitudes79-81 and is responsible for the increased concentration 
of hemoglobin and hematocrit.  Erythrocyte expansion is not seen within the first few days of 
altitude exposure.  Sawka and others (1996) found that erythrocyte volume did not change 
after 13-days of continuous high altitude exposure and that plasma volume decreased by 
around 10%.82  Other studies have shown similar results.83-86  An adequate plasma volume is 
quite necessary for cardiac function during maximal exercise and to ensure that blood can be 
properly transported throughout the circulatory system.  Decreased plasma volume will lead to 
a decline in venous return or preload, which diminishes stroke volume and cardiac output 
when heart rate remains unchanged or reaches a maximum. 
 Plasma volume loss at altitude can be attributed to a multiple factors, including 
dehydration, diuresis, plasma protein loss, and increased capillary hydrostatic pressures.  As 
discussed earlier, diuresis may be a response to the respiratory alkalosis caused by the 
increased ventilation at altitude, which in turn leads to a loss in total body water.  The 
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dehydration at altitude may also be a result of this diuresis, as well as high energy 
expenditures and poor access to water.  In the Sawka (1996) study, fluid intake was controlled 
to prevent dehydration and the weight loss observed was not nearly enough to account for the 
volume loss seen in the plasma.82  This study showed for the first time that decreases in 
plasma oncotic pressures and fluid volume were strongly correlated.  He suggests that initially 
this is due to increased capillary permeability, possibly followed later by an increase in 
protein degradation.   
 The magnitude of hemoconcentration appears to be related to the degree of hypoxic 
stress.  At higher altitudes, hemoconcentration and plasma volume loss is greater than at lower 
elevations.87  In fact, increased hemoglobin concentration from plasma volume loss is 
commonly believed to be the most important factor contributing to improvement in 
performance as acclimatization to altitude occurs.  Hemoconcentration increases the oxygen 
carrying capacity of the blood and contributes to increasing arterial oxygen content.  The 
remainder of the improvement in arterial oxygen content can be contributed to increased 
pulmonary ventilation and alveolar oxygen partial pressure.87  While the hemoconcentration 
does increase the oxygen carrying capacity, it does not improve the peripheral oxygen 
delivery limitations that occur at altitude during maximal exercise.88  Therefore, increasing the 
oxygen carrying capacity of the blood and enhancing O2 transport with acute exposure to 
altitude via hemoconcentration does not appear fully able to mitigate the decline in maximal 
exercise performance.   
Since the ergogenic effects of blood volume adjustments at altitude after 
acclimatization do not seem to be related to the increases in oxygen carrying capacity to the 
periphery, the role of these adaptations must be questioned.  One very possible explanation is 
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that the increased hemoglobin and arterial oxygen content allow for adequate oxygen uptake 
to occur.  
The observation that performance is improved at altitude in response to decreased 
plasma volume is contrary to what is typically seen at sea level. In fact, it is widely recognized 
that decreases in body fluids and plasma volume are detrimental to performance.  However, it 
has been shown that longer distance events were more greatly affected by plasma volume loss 
than events closer to V̇O2max effort.88  This could be due to the fact that a reduced plasma 
volume impairs thermoregulation by reducing the ability of the blood to reach the capillaries 
in the skin, and reducing the sweat rate.89  This would reduce heat transfer with the 
surrounding environment and possibly induce hyperthermia in longer endurance events.  At 
elevation, overheating is less common due to cooler temperatures. It is also possible that the 
improvements in performance of increased O2 transport may outweigh the decrements in 
performance due to the impaired thermoregulatory ability of the lower plasma volume state. 
In conclusion, we expect to see decreases in plasma volume throughout the duration of 
the altitude exposure in this study. The increase in ventilation would likely lead to a continued 
state of alkalosis, which would be counteracted with an increase in diuresis throughout the 
exposure time. We expect the reduction in plasma volume to increase CaO2, but mitigate 
V̇O2max and performance if all other variables remain unchanged.  We also expect plasma 
volume loss to be greater after 14 hours of hypoxic exposure than at 2 hours. 
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Effects of Acute Altitude Residence on Sleep Quality 
 Another possible variable affecting acute altitude performance relates to the changes in 
sleep quality after overnight residence in hypoxia.   A reduction in sleep quality at altitude is 
occasionally noted by subjects after ascension to high altitudes, particularly in the first few 
nights.90  Subjects often describe their sleep as poor quality with occasional awakenings 
throughout the night, and sporadically, a sensation of suffocation that is alleviated with a few 
deep breaths.90  Sleep at altitude is often characterized by periodic breathing, which consists 
of an increase then sharp decrease in hyperpnea followed by a brief period of apnea.  While 
this periodicity decreases with successive nights at altitude, it has been shown to persist at 
elevations above 4500m.91    
 Early studies on sleep physiology at altitude showed the alteration of sleep cycles 
experienced by subjects.  Joern et al. (1970) found that at pressures similar to moderate 
altitudes, sleep stage distribution was altered so that Stages 3 and 4 were almost eliminated 
and REM sleep was reduced by 50%.92  Similarly, Reite et al. (1975) showed significant 
reductions in Stages 3 and 4 and less REM sleep. The authors also noted the presence of 
periodic breathing among the subjects, although this periodicity disappeared once the subject 
shifted into REM sleep.  Arousals that occurred during the periodic breathing often followed 
the transition from the apneic to the hyperpneic stages of the periodic breathing cycle.4  
Interestingly, this study showed no significant decreases in overall sleep time and found that 
these changes were the greatest on the first night of arrival at altitude, and decreased as 
altitude residence persisted.  Subsequent studies have shown similar results.91,93-95  Although it 
appears that the increased arousals during sleep at altitude are connected to periodic breathing, 
the mechanisms that contribute to the shift in sleep patterns are poorly understood.90 
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 The mechanism of periodic breathing, though, was first demonstrated by Douglas and 
Haldane (1909).96  The authors showed that this breathing pattern was characterized by 
alternating intervals of hypoxia, which led to hyperpnea, and hypocapnia, which led to apnea. 
Essentially, the two respiratory responses (hyperpnea to hypoxia and apnea to hypocapnia) are 
at odds with each other under these conditions.  Thus, periodic breathing exhibits a cyclic 
condition. Hypoxia causes a stimulation of breathing which in turn decreases the partial 
pressure of CO2 in the blood.  This hypocapnia causes ventilatory drive to be inhibited, 
leading to apnea, which leads to further hypoxia.  During sleep at altitude, this cycle continues 
to occur, except during REM sleep.  They also argued that while the subjects were awake, the 
rhythmic nature of breathing allowed the subjects to maintain normal breathing patterns, even 
without the normal respiratory stimuli seen at lower altitudes.  During sleep, this rhythm is 
lost as the strong inhibitory respiratory drive of the hypocapnia caused a predisposition 
towards apnea.  Later studies verified this mechanism.4,97,98  Some of these later studies also 
showed that this periodic breathing cycle was dependent on the ventilatory sensitivity of the 
subject to hypoxic exposure. 
 While this phenomenon has been shown to persist at very high altitudes (>4,500m), 
studies have shown that periodic breathing declines during subsequent nights at moderate 
altitudes.91,99  It is important to note that this occurs despite the fact that hypocapnia increases 
over time. As such, it appears that the responsiveness of the ventilatory inhibition by 
hypocapnia is improved with acclimatization to altitude. 
 The greatest effect of periodic breathing is the reduction in sleep quality marked by an 
increase in arousals and awakenings.  These sleep disturbances occur primarily when the 
periodic breathing cycle shifts from apnea to hyperpnea.  It is possible that the disturbances 
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are triggered by apnea-induced asphyxia, the mechanics of the initiation of breathing, or 
simply as a consequence of the central commands that instigate breathing.90  It has been 
shown that at low altitudes, sleeping during ventilatory stimulation by the application of 
various respiratory loads, as well as hypoxia and hypercapnia, leads to arousals in response to 
the mechanics of the increased respiratory effort rather than changes in blood gases.100  This 
suggests that the mechanics of the periodic breathing cycle may cause the sleep disturbances. 
 While it is clear that sleeping at very high altitudes results in awakenings and 
disturbances among most subjects, one would expect to see fewer cases of periodic breathing 
and sleep disruption as the elevation of residence is decreased. The thresholds at which these 
effects are seen are not well established. However, a study by Muhm and others (2009) 
observed the changes in sleep quality at 2,438m, very close to the simulated elevation of the 
current study.   The authors found that although there was a moderately severe occurrence of 
hypoxemia, there were no observed changes or reductions in sleep quality.101  Another, more 
pertinent study that makes use of a normobaric hypoxic tent, which is the method of 
simulating overnight altitude in the current study, found that subjects reported lower scores on 
a questionnaire designed to measure quality of sleep. However, more objective measurements 
made in the study showed no changes in stages 3 and 4 or in REM sleep. Stages 1 and 2 were 
reported to be significantly shorter than in normal conditions, but the authors acknowledge 
that this is likely to be due to familiarization to the new environment.102  While it is unclear if 
physiological variables are to blame for decreased sleep quality at this moderate altitude, the 
primary measure of this study is performance, so sleep disruptions due to environmental 
changes must be acknowledged as well. 
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Summary 
 Endurance performance at moderate altitudes is modulated by the reduced partial 
pressures of oxygen in the hypobaric environment.  Acclimatization strategies are employed 
by athletes to ameliorate some of the performance decrements.  For athletes limited to short-
term arrival strategies (i.e. < 24 hours), several factors may alter performance over the first 
few hours of acute altitude residence.  Arrival at altitude is accompanied by an increase in 
ventilation in response to the hypoxic environment. The increased ventilation is likely to 
persist for some time after the initial escalation, but the time course over the first 14 hours of 
altitude exposure are not well characterized.  After initial altitude exposure, plasma volume 
can be expected to decrease, and again, the time course of the decline over the first 14 hours 
of altitude exposure is not known.  The effects of this decrease on performance is somewhat 
unclear, since the hemoconcentration increases the carrying capacity of the blood, but also 
limits the venous return to the heart affecting cardiac function.  Sleep quality may also be 
affecting performance with acute exposure to altitude. While the occurrence of periodic 
breathing is well-documented at high altitudes, it has not been shown at moderate altitudes 
and sleep quality measures in these studies don’t adequately measure the physiological 
parameters. 
 The knowledge of these previous studies will allow us to develop and implement a 
novel study that investigates the physiological and performance changes in short-term arrival 
strategies at moderate altitude. 
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Chapter 3 
Procedures 
 This study required subjects to visit the lab on five occasions separated by at least five 
days. The first two visits to the lab consisted of a qualification trial and a familiarization trial.  
With the exception of the variation in hypoxic dosage, the subjects performed identical pre-
exercise and exercise protocols on each of the final three experimental trials.  The protocol for 
the experimental trials consisted of an overnight stay in a hypoxia-compatible tent, two hours 
of resting in the laboratory, and a 20km time trial on a cycle ergometer.  The experimental 
trials consisted of:  (1). an overnight stay (12 hours) at simulated altitude of 2,500m (FiO2 = 
16.2%), two hours at FiO2 = 16.2%, a 20km time trial on the cycle ergometer at FiO2 = 16.2%; 
(2). an overnight stay (12 hours) at 235m (Bloomington) in normoxia, two hours at FiO2 = 
16.2%, a 20km time trial on the cycle ergometer at FiO2 = 16.2%; (3). an overnight stay (12 
hours) at 235m, two hours at 235m, a 20km time trial on the cycle ergometer at 235m.  The 
three experimental trials were randomly assigned and the subjects were blinded to the hypoxic 
dosage that they received for each trial.  
 
Subjects 
 The subject pool consisted of healthy, actively training men who were elite endurance 
runners and cyclists who were non-smokers and had no history of cardiovascular, pulmonary, 
or renal disease.  The minimum requirement for V̇O2max on a cycle ergometer for inclusion 
was set at 55 ml min-1 kg-1.  A questionnaire was used to determine training status and 
medical history.  Subjects were advised both orally and in writing as to the nature of the 
experiments and obtained written consent prior to testing, in accordance with policies and 
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procedures of the Institutional Review Board of Indiana University.  Subjects were asked to 
refrain from strenuous workouts in the 48 hours prior to each time trial, but to otherwise 
maintain their normal training volume and intensity. 
 
Timeline Delineating Exercise Protocols 
Figure 4. Timeline of Events (minimum)  
 
 
Graded Exercise Test Protocol 
 After arrival at the lab on the first day, subjects were instructed on the use and protocol 
for an electronically-brake cycle ergometer (Velotron RacerMate) and allowed to adjust the 
seat and handlebar height as necessary.  The subject then sat quietly on the cycle ergometer 
and was fitted with a heart rate monitor and face mask.  Once all equipment was in place, the 
subject rested for 5 minutes and metabolic data was collected.  The initial power output was 
set at 100 watts for 1 minute.  After the first minute, the power output was increased by 25 
watts every minute until volitional fatigue.103  Criteria for determining V̇O2max included: (1) 
a heart rate of within 10% of age-predicted maximum; (2) a plateau in oxygen consumption 
(<150 ml O2) with an increase in workload and (3) a respiratory exchange ratio of greater than 
1.10.  The subject was required to have met two of the three criteria for the V̇O2max test to be 
valid.  The highest recorded value for V̇O2 was considered to be V̇O2max. 
 
Graded Exercise 
Protocol 
Experimental 
Trial #3 
20 Kilometer 
Familiarization Trial 
Experimental 
Trial #1 
Experimental 
Trial #2 
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Familiarization 20-km Time Trial Protocol 
 For second visit to the lab, the subject was fitted with a heart rate monitor, and mask.  
The subject was instructed to traverse the 20 kilometer distance on the cycle ergometer as 
quickly as possible and with maximum effort.   The subject was allowed a 10 minute warm up 
at 50% of V̇O2max before the start of the trial.  After the warm up period, the subject was able 
to set his own power output and cadence, which the subject could change at any point 
throughout the trial.  Metabolic data was collected for the duration of the performance trial.  
Also, verbal encouragement was provided to the subject throughout the trial.  Time to 
completion and instantaneous power output was collected in addition to the metabolic and 
ventilatory data. 
 
Intervention Trials Protocol 
 On the third through fifth lab visits, subjects took part in blinded and randomized trials 
including: a) 12 hours overnight at 2,500m simulated altitude (normobaric hypoxia) followed 
by a 2 hour-hypoxic dose in the laboratory and a 20km time trial at 2,500m, b) 12 hours 
overnight at 235m followed by a 2-hour hypoxic dose at 2,500m in the laboratory and a 20km 
time trial at 2,500m, and c) 12 hours overnight at 235m followed by a 2-hour normoxic dose 
in the laboratory and a 20km time trial at 235m.   
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Sleeping Protocol 
 For each experimental trial, subjects came into the lab at approximately 1800 hours 
and after consuming a meal.  Subjects were instructed to consume 15ml/kg of water in the 
hour prior to this.  Upon arrival, a urine sample was collected, and specific gravity was 
measured.  A specific gravity of 1.010 was set as the criteria to determine that the subject was 
euhydrated.  Body mass of the subjects was taken after allowing them void and drink water as 
desired.  Beginning at this time point, the volume of urine output was recorded throughout the 
trial.  Subjects then immediately completed the CO rebreathe method described in detail later 
in this section.  Subjects wore Actical multi-directional accelerometers on one wrist and a 
fingertip pulse oximeter on the other wrist prior to entering the altitude tent.  Actical data was 
collected for the duration of the altitude exposure and analyzed from the time the subjects 
went to sleep until waking the following morning.  The time that the subjects attempted to 
sleep was the same across all three trials.  For the sleeping trial in hypoxia, the altitude in the 
tent was set to a simulated 2,500m by using a commercially available nitrogen generator 
(Colorado Altitude Systems, Denver, CO) to add nitrogen to the tent until O2 concentration 
was 16.2%.  The tent was constructed of PVC pipe and plastic sheeting in a cubic formation 
measuring 2.7m x 2.7m x 1.7m, which was placed over top of a standard queen size bed 
located in the Human Performance Laboratory.  Temperature, O2, and CO2 concentrations in 
the tent for all trials were continuously monitored via Applied Electrochemistry (Thermox 
instruments, Pittsburgh, PA) O2 and CO2 monitors.  The subjects then entered the tent and the 
subjects were required to remain in the tent except if they needed to defecate (bedside urinals 
and drinking water were provided in the tent).  Subjects were allowed to eat and drink ad 
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libitum while in the tent.  The subjects were also allowed to read, use electronic devices, or 
listen to music in the tent. 
 
 
Pre-time trial protocol 
The 20k time trial was scheduled for 14 hours after the subject entered the hypoxic tent.  
Subjects were required to be awake and begin a pre-time trial routine at least two hours prior 
to the scheduled starting time of the time trial.  Subjects were required to remain in the tent 
until 30 minutes prior to the start of the time trial, but had adequate room in the tent to 
complete stretching and other pre-warm up activities.  For the 12 hours of normoxia / 2 hours 
of hypoxia trial, 100% nitrogen gas was flowed into the tent beginning 2 hours prior to the 
start of the time trial, and normally took 15 minutes to equilibrate at the desired simulated 
altitude.  Once awake, the subjects filled out a questionnaire to compare differences in sleep 
quality and sleep disturbances. 
 
Time Trial Protocol 
The cycle ergometer seat was set to the same height the subject used in the 
familiarization trial, and the subject was fitted with a heart rate monitor.  The subject then 
completed a standardized warm up protocol of 10 minutes of cycling at a workload equal to 
50% of V̇O2max, followed by 3-5 minutes of rest to collect resting metabolic and ventilation 
data. After the 3-5-minute rest period, the subject was asked to begin the time trial and to 
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attempt to complete the 20-km as quickly as possible.  The subject was free to alter cadence or 
resistance freely throughout.  The subject was provided with continuous visual feedback of 
distance traveled.  A verbal notice of kilometers remaining was given each kilometer, starting 
with 5km to go.  During these trials, the subject breathed air containing 16.2% O2 or room air, 
and metabolic data was collected every 15 seconds for the duration of the trial.  We recorded 
time to completion at the end of the trial and instantaneous power throughout the trial. 
 
Determination of Plasma Volume 
 A 2-minute CO rebreathing method, as described by Gore104 was used to determine 
total hemoglobin mass, which combined with hemoglobin concentration and hematocrit 
allowed for the calculation of plasma volume.  In brief, we measured initial percent of 
hemoglobin bound to carbon monoxide (%HbCO) by taking a 100 uL capillary blood sample 
from a fingertip and using a radiometer OSM3 blood gas analyzer (Radiometer Medical A/S, 
Copenhagen).  The subject was fitted with noseclips, exhaled to residual volume, then placed 
their mouth on a mouthpiece connected to a homemade spirometer.  The subject then inhaled 
a bolus of 99.5% CO (1 ml/kg body weight) that was delivered using a 100-ml plastic syringe, 
and rebreathed from the spirometer connected to a 5L anesthetic bag filled with 100% O2. The 
subject then rebreathed from this spirometer for 2 min.  After the 2-minute breathe was 
completed, a handheld parts-per-million (ppm) CO analyzer (Fluke model CO-220, Canada) 
and a Stead-Wells spirometer (Collins Medical, Braintree, MA) were used to quantify the 
volume of CO in the spirometer that was not taken up by the body.  The %HbCO 
measurement (via finger prick) was repeated at 6 and 8 min after the start of the rebreathe and 
averaged.  A correction was made to account for the volume of CO that was expelled from the 
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lung after removing the spirometer. This was done by measuring end-tidal CO concentration 
at the fifth minute after the start of the procedure and multiplying by the estimated alveolar 
ventilation (15 L/min) between minutes 2 and 5.  Plasma volume was calculated from Hbmass 
and measures of hematocrit and hemoglobin concentration.  This CO rebreathing procedure 
was performed after arrival at the laboratory, before entering the tent for the evening.  It was 
assumed that total Hbmass did not change during the 14 hour tent exposure, and hematocrit 
measures taken pre- and post-time trial were used to determine changes in plasma volume. 
 
Sleeping arterial oxyhemoglobin saturation 
 To determine sleeping arterial oxyhemoglobin saturation, we used a fingertip pulse 
oximeter (Model PC-68A, Shenzen Creative Industry Co, Ltd., Shenzen, China).  This device 
consisted of a wristband oximeter and a fingertip probe that measured saturation percentage of 
oxygen in the blood (SpO2).  Prior to entering the tent, subjects were fitted with the wristband 
and fingertip probe and data collection was initiated. Subjects wore the device throughout the 
night, and the device recorded heart rate and SpO2 data every 3 seconds.  
 
Measures of sleep quality  
 To measure the quality of sleep in the altitude tent, wrist activity monitors (Actical, 
Mini-Mitter Co, Inc., Bend, Oregon) and an altitude-validated survey instrument (the 
Groningen Sleep Quality Questionnaire) were used.105  The subjects were given the Actical 
monitors prior to entering the tent and asked to wear them on their wrist once they went to 
bed.  The starting point for this measure was set at the time the subjects went to bed and the 
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end point was set at the time the subjects woke up in the morning.  The duration of this 
measurement was consistent for all trials.  Upon waking in the morning, the monitors were 
removed and subjects were asked to fill out the questionnaire immediately.  The Actical 
monitors record movement counts, which were uploaded onto the device’s data management 
software to track disturbances during the night.  Total activity counts were recorded during the 
sleeping period to compare movement in sleep between trials. 
 
RPE and Dyspnea scales  
 To determine the perception of each subject’s exercise intensity, Borg’s RPE scale was 
used.106  After every the completion of every 4k, we showed a printed version of the scale to 
the subject and instructed them to point to the number corresponding to their perceived level 
of exertion.  We also used the Modified Borg scale for Perceived Dyspnea as described by 
Burdon (1982).107  This scale was shown to the subjects concurrently with the RPE scale at 
the end of every 4k portion of the time trials. 
  
Ventilatory and Metabolic Measurements 
 Indirect calorimetry was used to measure ventilatory and metabolic variables via a 
computer interfaced, open circuit system.  A linear pneumotachometer (Hans-Rudolph Inc., 
Shawnee, KS) was used to measure minute ventilation (VE) on the inspired side of the 
breathing apparatus.  The inspired line was connected to a two-way non-rebreathing valve 
(#2700, Hans-Rudolph Inc., Shawnee, KS).  The hose from the expired side of the mouthpiece 
was connected to a 5-L mixing chamber.  An Applied Electrochemistry S-3A oxygen analyzer 
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and a CD-3A carbon dioxide analyzer (AEI Technologies, Pittsburgh, PA) continuously 
sampled 300 cc/min of the dried expired gas from the mixing chamber to measure fractional 
concentrations of oxygen (FEO2) and carbon dioxide (FECO2) gas in the chamber.  The 
analyzers were calibrated with a gas of known composition within the expected physiologic 
range, both before and after exercise testing.  These variables were measured and monitored 
with a data acquisition, control, and analysis software (DASYLab Version 12, Measurement 
Computing Corporation, Norton, MA). All gas measurements (V̇E, V̇O2, and V̇CO2) were 
corrected to STPD. Heart rate was continuously monitored using telemetry (Model FT1, 
Polar, Stamford, CT). 
 
Statistical Analysis 
 Separate one-way repeated measures ANOVAs with Tukey’s post-hoc analysis were 
used to determine differences between means of select dependent variables (e.g. time trial 
completion time, average power, change in plasma volume, sleep quality) across the three 
experimental conditions.  A two-way repeated measures ANOVA (condition x time) with a 
priori tests of simple main effects was used to determine differences in time trial variables at 
each 4km split across the three conditions.  An alpha of p < 0.05 was used as the criteria for 
statistical significance. 
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Chapter 4 
Results 
Subjects 
 Subject characteristics are shown in Table 1.  Ten subjects completed the entire 
protocol, while two of the originally recruited subjects dropped out due to time constraints and 
thus were not included in the analysis.  In terms of typical mode of exercise used in training, 
five of the subjects were trained cyclists and five of the subjects were runners.  There were no 
statistical differences between these two groups, so the data for both cyclists and runners was 
considered together.   
Table 1. Subject Characteristics 
 Mean ± SD 
Body Mass, kg 70.38 ± 7.73  
Age, yrs 23 ± 4  
V̇O2Max, ml·kg-1·min-1 66.5 ± 5.2  
Hematocrit, % 44.0 ± 3.0 
Total hemoglobin mass, g 967 ± 106 
 
Environmental Parameters 
Temperature and FiO2 in the laboratory and in the tent were closely monitored 
throughout the study, and there were no significant differences between the hypoxic trials for 
these variables. The only observed difference between the environmental parameters for the 
hypoxic and control trials was FiO2 (Table 2). 
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Table 2. Environmental Parameters (Mean ± SD) 
 Sleep Temperature  
(˚C) 
Ride Temperature 
(˚C) 
FiO2 – Tent 
(%) 
FiO2 – Ride 
(%) 
2hr 20.2 ± 0.3 20.4 ± 1.3 16.2 ± 0.2*  16.2 ± 0.0* 
14hr 20.2 ± 0.5 20.0 ± 1.5 16.0 ± 0.2* 16.2 ± 0.0* 
CTRL 20.2 ± 0.3 20.5 ± 1.2 20.2 ± 0.2 20.7 ± 0.2 
* Significantly different from Control (p < 0.05) 
 During sleep, SaO2 was significantly lower at each time point in the first 12 hours of 
tent exposure for the 14hr trial than both the 2hr time trial and the control.  However when the 
subjects awoke and were exposed to hypoxia in the 2hr trial, SaO2 dropped abruptly, to levels 
even lower than the 14hr trial at the time the time trial started.  (See Fig. 5) 
 
Performance 
 There were no statistical differences in time to completion for the 20km time trial 
between the 2-hour and 14-hour exposure trials.  A mean difference of 4.2s for a 20km ride 
was observed between the 2hr and 14hr time trials.  Performance times were significantly 
faster in the normoxic control trial than both of the hypoxic trials (See Fig. 6).   
  
Figure 5.  SaO2 during sleep and rest period prior to 20km time trial.  Values are means; error bars omitted for 
clarity. 
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Figure 6. 20km Time Trial Performance 
 
 
 
 
 
 
 
No differences were seen in overall completion times between any of the three trials.  When 
comparing the two hypoxic trials, no differences in pacing strategy were observed. (See 
Figure 7 & 8) 
Figure 7.         Figure 8. 
 
 
* * * * 
* 
* 
* 
Time to completion for subjects in the 20km time trial. Values are means ± 
SD.  * = P < 0.05 compared to both 2hr and 14hr trials. 
* * 
* 
Performance measures in 4km increments.  Figure 3) time to complete each 4km increment (x-axis shows 
distance ridden at the end of each increment.) Figure 4) Average power for each 4km increment (x-axis 
shows distance ridden at the end of each increment.).  Values are means; error bars omitted for clarity.       
* = Significantly different from 14hr and 2hr, p < 0.05 
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Metabolic Variables During Exercise 
 Few differences were seen between metabolic variables measured during the exercise 
bout between the 14hr and 2hr trials, although (as expected) many of these measures were 
significantly different than the control trial.  Measures taken during the ride, reported as 
minute averages at the end of each 4km, are summarized in Table 3. 
Table 3. Values displayed as Mean ± SD 
 n 4km 8km 12km 16km 20km 
V̇O2, ml·kg-1·min-1 
    2hr 
    14hr 
    CTRL 
10 41.4 ± 4.7 44.3 ± 5.3 44.1 ± 5.2 44.4 ± 5.8 46.6 ± 6.4 
10 41.7 ± 7.4 44.4 ± 7.8 45.0 ± 7.4 45.2 ± 8.0 48.0 ± 10.3 
10 42.9 ± 7.1 45.8 ± 7.2 46.5 ± 7.1 46.1 ± 7.1 49.0 ± 7.7 
SaO2, %  
    2hr 
    14hr 
    CTRL 
10 89.5 ± 3.5* 89.8 ± 3.4* 89.9 ± 2.8* 89.7 ± 2.8* 89.6 ± 3.1* 
10 89.8 ± 4.3* 89.0 ± 4.2* 89.4 ± 3.9* 89.6 ± 3.8* 89.9 ± 3.4* 
10 95.5 ± 2.0 96.4 ± 1.5 97.0 ± 1.7 96.1 ± 2.4 93.8 ± 6.2 
Heart Rate, bpm 
    2hr 
    14hr 
    CTRL 
10 163 ± 9 164 ± 11 167 ± 13 167 ± 12 177 ± 11 
10 161 ± 11 164 ± 11 165 ± 12 167 ± 16 178 ± 12 
10 160 ± 13 162 ± 13 164 ± 14 166 ± 15 179 ± 12 
V̇E/ V̇O2 
    2hr 
    14hr 
    CTRL 
10 34.4 ± 7.0* 33.4 ± 5.1 33.8 ± 5.5 32.9 ± 4.4 35.9 ± 5.4 
10 32.3 ± 6.1 32.2 ± 5.8 32.7 ± 5.3 32.4 ± 5.2 34.9 ± 5.6 
10 31.1 ± 7.9 30.4 ± 5.7 30.8 ± 6.5 29.9 ± 5.6 34.3 ± 5.9 
V̇E/ V̇CO2 
    2hr 
    14hr 
    CTRL 
10 36.1 ± 6.7* 36.8 ± 6.0* 37.3 ± 6.7* 37.7 ± 6.3* 38.8 ± 5.6* 
10 36.3 ± 5.2* 37.3 ± 5.4* 38.8 ± 5.5* 39.3 ± 5.8* 41.6 ± 6.5* 
10 30.9 ± 5.1 31.8 ± 5.4 32.8 ± 5.4 32.7 ± 5.9 34.7 ± 5.6 
V̇E, L·min-1 
    2hr 
    14hr 
    CTRL 
10 85.2 ± 4.0 80.8 ± 6.0 83.6 ± 5.6 81.6 ± 4.2 99.5 ± 3.9 
10 81.4 ± 4.8 80.4 ± 7.6 82.6 ± 5.1 84.3 ± 3.7 102.1 ± 7.6 
10 78.8 ± 4.0 77.3 ± 4.8 72.4 ± 9.9 78.6 ± 7.2 104.0 ± 7.8 
ETCO2, % 
    2hr 
    14hr 
    CTRL 
8 3.96 ± 0.52* 3.91 ± 0.53 4.02 ± 0.45 3.92 ± 0.42 3.63 ± 0.28# 
8 4.03 ± 0.53 3.96 ± 0.40 3.81 ± 0.34 3.75 ± 0.32* 3.51 ± 0.38* 
8 4.42 ± 0.66 4.32 ± 0.72 4.17 ± 0.62 4.24 ± 0.59 3.90 ± 0.39 
* Significantly different from Control trial (p < 0.05) 
# Significantly different from 14hr trial (p < 0.05) 
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During the ride, no differences were seen for SaO2 values between the 2hr and 14hr 
trials.  The values for both of these trials were significantly lower than the values for the 
control trial (p < 0.05). (See Fig 9) 
Figure 9.  SaO2 during 20km time trial 
  
 
Ventilatory Acclimatization 
Most of the variables for ventilatory acclimatization showed no change between the 
2hr and 14hr performance trials.  End-tidal CO2 and V̇E/V̇O2 were not significantly different 
across conditions at any of the time points for any of the trials (See Fig. 10 and 11).  V̇E 
/V̇CO2 approached significance for the 14hr trial over the 2hr trial at the 16km and 20km 
marks (p = 0.091 and p = 0.076 respectively). For the 14hr trial, FETCO2 was significantly 
lower than the control trial at the 16km and 20km marks, and significantly lower than the 2hr 
trial at the 20km mark. 
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Figure 10.  ETCO2 during time trial     Figure 11. VE/VO2 during time trial 
 
 
Changes in Plasma Volume 
 Plasma volume decreased in all trials from the time the subjects entered the tent until 
the end of the ride.  There was a significantly greater decline in plasma volume at both the 
pre-ride and post-ride time points during the 14hr trial compared to both the 2hr and control 
trials (p < 0.05). (See Fig. 12) 
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Figure 12. Plasma volume loss from night prior to before and after time trial 
   
 
 
The mean loss in plasma volume overnight during the 14hr trial was 235 ml more 
(44%) than the plasma volume lost during control.  During the 2hr trial, however, only 22ml 
more (7%) plasma was lost overnight than during control.  The difference in plasma volume 
loss between the 2hr and 14hr time trial (223ml) is very similar to the difference in urine 
volume for the same two trials (280ml). (See Fig. 13 and Fig. 14) 
 
 
 
 
 
 
 
 
Values are means + SD.   
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Figure 13. Plasma Volume loss overnight    Figure 14. Urine volume loss overnight 
  
 
 
 
Measure of Sleep Quality 
 No differences were seen between any of the measures of sleep quality for any trial 
during this study.  Activity counts during sleep were 744.7 ± 30.2 for the 2hr trial, 740.9 ± 
31.7 for the 14hr trial, and 752.3 ± 28.5.  Survey data (n=8) also showed no differences in 
sleep quality between trials. See Fig. 15 & 16. 
    Figure 15.      Figure 16. 
   
*Significantly different than 2hr trial and control (p < 0.05) 
 
*Significantly different than 2hr trial and control (p < 0.05) 
 Values are means + SD.   
 
Values are means + SD.   
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Perceived Exertion and Dyspnea 
 No differences were seen in either of the measures of perceived effort during any of 
the three trials.  Rating of perceived exertion (RPE) was not different with the other trials at 
any of the time points taken.  The same was true for rated dyspnea.  (See Fig. 17 and 18)  
 
Figure 17. RPE during time trial  Figure 18. Dyspnea rating during time trial 
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Chapter 5 
Discussion 
 In this investigation, the primary outcome variable was time trial performance, and in 
this regard, we found no difference between the 14h and 2h conditions.  No statistical 
differences were seen in V̇E/ V̇O2, ETCO2, V̇E, or V̇E/ V̇CO2 between the hypoxic trials, 
meaning that our study failed to show an increase in ventilatory drive between the two 
hypoxic trials.  Greater plasma volume loss was noted for the longer hypoxic exposure time.  
While no significant difference was found between the 2hr and control trials, the loss in 
plasma volume after 14 hours in hypoxia was 223mL more than the 2hr trial.  This difference 
accounted for a 6% decrease in plasma volume between the two trials.  As such, the primary 
outcomes of this study were: a) There were no significant changes in performance times 
between 14h and 2h of hypoxic exposure, b) plasma volume was significantly decreased after 
a longer duration at altitude (14h vs 2h), c) ventilation was not different after 14h than after 2h 
of hypoxic exposure, and d) no identifiable differences were noted for sleep quality between 
conditions.  From a practical performance standpoint, this difference in ride times between 
hypoxic exposures is of minimal consequence.  However, important differences were found 
between select dependent variables that may help to elucidate the time course of changes seen 
for this duration of hypoxic exposure.  We hypothesized that an increase in ventilatory drive 
would be beneficial to exercise performance at altitude; however, it appears that any gains 
may have been offset by the decrease in plasma volume as a result of the 14 hour exposure to 
hypoxia that produced an increase ventilatory drive during exercise.  Since no other studies 
have looked at the effects of hypoxic exposure on performance at these time points, this 
finding is novel. 
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Altitude Exposure and Performance 
 This study gives an important insight into the time course of the important 
physiological changes seen with short term exposure to altitude and how those variables may 
affect performance.  Previous work has shown that at least 14 days of hypoxic exposure is 
ideal for acclimatization for endurance exercise performance at moderate altitude,2 but many 
athletes and coaches do not have the resources or flexibility to achieve this duration of 
acclimatization prior to an altitude competition.  Many coaches believe that there is a 
difference between these brief exposure periods, and this question is the subject of 
considerable debate.3  Ventilation, plasma volume, and sleep quality are each known to 
change significantly with acclimatization to altitude,4,17,82 but the relationship between the 
timing and magnitude of these adaptations and performance outcomes have not been clearly 
elucidated.  Many coaches and teams have adopted a “fly in, fly out” strategy,5,6 in which as 
little time as possible is spent at altitude both before and after the competition so perceived 
negative acclimatization responses, such as reduced sleep quality and plasma volume 
decrements, are mitigated.  Conversely, other athletes will typically arrive the night prior to 
the competition, with little concern about any short term acclimatization effects on 
performance.  While it is clear that 1-2 weeks of altitude residence is preferential to day-prior 
or same-day arrival for exercise performance at altitude, differences in short term arrival 
strategies of <24 hours have not been adequately researched. 
 We hypothesized that 20km cycle performance times in hypoxia (simulated 2500m) 
would be faster after 14 hours of hypoxic exposure as opposed to two hours of hypoxic 
exposure.  Our findings, though, contradicted this hypothesis as no differences were found in 
performance between the two trials.  Since no differences were seen in pacing strategy, heart 
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rate, dyspnea, and RPE and the subjects were highly motivated, it can be assumed that the 
subjects gave equivalent efforts in each of the trial conditions.  There are relatively few 
studies that investigate endurance performance changes at 2500m elevation.  One such study, 
by Wehrlin et al.(2006), demonstrated a 6.3% drop in V̇O2max for every 1000m of elevation 
change, as well as a 14.3% decrease in time to exhaustion for a supramaximal (107% of 
vV̇O2max) exercise protocol for every 1000m of elevation change.46  However, even fewer 
studies have looked at submaximal exercise performance at these altitudes.  The most 
pertinent study by Weston et al. (2001),3 which observed the effects of the time course of 
altitude exposure on the performance of youth rugby players, suggests that we might see an 
improved performance in the 14hr trial against the 2hr trial.  However, this divergence in our 
results versus those of Weston et al. could be explained by a variety of factors, including 
exercise mode, subject characteristics, and exercise duration.  The subjects in the Weston 
study were high school students from a rugby club and performed a push up test and a shuttle 
run test that only lasted about 5-7 minutes on average, while subjects in the current study were 
highly trained endurance athletes who performed a 20km cycling time trial.  Also, the 
exposure times for the Weston study were 6 and 18 hours, which may result in different 
acclimatization responses.    In our study, differences were seen between the control trial and 
both hypoxic trials, suggesting that our simulated altitude was high enough to induce 
considerable performance decrements.   
Altitude Exposure and Plasma Volume 
The magnitude of overnight plasma volume decrease was found to be dependent on 
the duration of altitude exposure.  A significant decrease in plasma volume can be assumed to 
lead to an impairment in cardiac function, as a result of an insufficient preload.  After 14 
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hours of hypoxia, plasma volume dropped 223mL more than after two hours or control.  This 
occurred despite the fact that subjects were allowed to drink water throughout the night.  The 
average overnight plasma volume loss during the 14 hour and two hour trials was 18.5% and 
13% respectively.  These values are slightly higher than other studies, which report plasma 
volume loss close to 10% at sea level over the course of 24 hours of bedrest and 4% of this 
occurring in the first 6 hours.  Many of these studies have also shown a fairly large individual 
variation.87,108  Armstrong et al. have shown significant performance decrements in distance 
runners for 5000m and 10000m time trials when plasma volume is decreased by about 10%.88  
Since the reductions in performance from the Armstrong study were substantial (2.62 min for 
10000m), it is likely the plasma volume reduction had a practically significant impact on the 
time to completion for the subjects in this study.  If we extrapolate this difference to the 18% 
plasma volume loss observed for the 14hr exposure in this study, we could estimate a 
potential difference of 4.85 min difference from control.  This method would also suggest a 
difference of 3.41 minutes between the 2hr and control.  Since no changes were seen in 
performance between the 2hr and 14hr trials, an opposing adaptation is likely occurring at the 
same time. 
Altitude Exposure and Ventilatory Changes 
Ventilatory changes during exercise did not appear to be related to the time spent in 
hypoxia.  While no statistical differences were noted, the p-values for V̇E/ V̇CO2 during the 2hr 
and 14hr trials were somewhat close to significance over the last two stages of the time trial (p 
= 0.091 at 16km and p = 0.076 at 20km.  Any increase in ventilation that occurred with 
increased duration of altitude exposure may have facilitated an improved O2 delivery in 
relation to the two hour trial.  An increase in ventilatory drive can increase the pressure head 
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for O2 diffusion in the lung, thus helping to maintain CaO2.  However, this does not come 
without consequences, as an increased ventilatory drive also means an increased cost of 
breathing.  At altitude, the partial pressure of O2 is depressed, resulting in a decreased bulk 
flow of O2 into the lungs.  Peripheral chemoreceptors in the carotid bodies sense the decreased 
PO2 in the arterial blood, and subsequently stimulate the respiratory center in the brain to 
increase ventilation.  This phenomenon, termed the hypoxic ventilatory response (HVR)109,  
would be greater after an increased duration of altitude residence, however our observed 
changes in ventilatory variables were somewhat unclear.  Statistical changes were not seen in 
the respiratory measures taken, and no definitive increases in ventilatory acclimatization were 
noted.       
Altitude Exposure and Sleep Quality 
Sleep quality was not adversely affected by duration of altitude exposure in the current 
study.  There were no differences in activity counts or scores on the Groningen Sleep Quality 
Questionnaire, and no apparent changes due to altitude duration on this measure.  Scores 
below 2 on the questionnaire are described as “normal” and above 6 as “disturbed”.105  Since 
the average scores for all 3 trials were between 4 and 6, it is likely that our subjects 
experienced somewhat poor quality sleep, regardless of condition.  The generally poor sleep 
may have been due to the ambient lab conditions and the unfamiliarity with the environment 
for the subjects.  Specifically, sleeping in a different bed than their own and the noise of the 
nitrogen generator and laboratory equipment may have affected sleep responses.  It is possible 
that these conditions masked any possible sleep quality impairments as a result of altitude 
residence.  As a result, it appears that no effect on performance can be attributed to sleep 
quality changes in this study.  Sleep at altitude is often characterized by periodic breathing 
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which is correlated with more arousals, although sleep is has been shown to be more disrupted 
at altitude regardless of the amount of periodic breathing.110  These factors typically lead to 
sleep disruptions at altitude that reduce the quality of sleep for individuals during altitude 
residence that do not appear to diminish over the first few nights at altitude.95,110  However, 
many individuals experience sleep disruptions in unfamiliar environments regardless of 
altitude.  The current study showed that the disruptions in sleep were not greater at altitude 
than they were from simply sleeping in a new environment, as there was no difference in sleep 
quality between the altitude conditions and control (normoxia).  No order effect was observed.  
Our data would suggest that individuals who have to travel to competitions may experience 
sleep disruptions regardless of the altitude in which they sleep.    
Implications 
 Making broad recommendations for arrival strategies as a result of this study could be 
complicated by the likelihood for individual variation in response to altitude exposure of this 
duration.  Some of the subjects in this study performed better with 14 hours of exposure and 
others performed better with only 2 hours, although most of the subjects had almost identical 
completion times for the two hypoxic trials (7 of the 10 subjects had < 0.3 min difference).  
Individual variations in physiological adaptations to altitude are likely the cause for the 
divergence seen between these individuals.  Individuals who have a greater increase in 
ventilatory drive are likely to benefit from a greater time spent at altitude.  Individuals who 
have a small increase in ventilatory drive are likely better off implementing a shorter altitude 
duration to minimize the effects of plasma volume loss and potential sleep disruption.  
Conversely, if an athlete experiences a great deal of water loss at altitude, they may wish to 
forego the increased ventilatory drive associated with longer hypoxic exposure.  Practically, 
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the athlete has the difficult task of balancing these two opposing adaptations and finding the 
approach that has the greatest benefit to his or her individual physiology. 
Limitations 
A few notable limitations were observed during this study.  Due to logistical 
difficulties and the blinded nature of this study, the hypoxia was created in normobaria, rather 
than the hypobaric hypoxia found at actual altitude.   The potential differences in responses to 
the divergent barometric pressures have been well studied in the literature, albeit typically as a 
pre-acclimatization tool.  Hypobaric hypoxia seems to be more effective at bringing about 
acclimatization than normobaric hypoxia,111  therefore it is possible that the magnitude of 
physiologic changes could be greater in hypobaric hypoxia  Another potential limitation is the 
influence of the laboratory conditions on sleep quality.  Many of the subjects noted discomfort 
and difficulty of sleep within the laboratory that could not be avoided, due to use of the 
hypoxic gas generator, analyzers, and other laboratory equipment being used in the study.  
Also, the logistics of having a bed within the tent that could be taken down to allow for 
movement within the tent meant that a high quality air mattress had to be used instead of 
traditional bedding.   
Future Directions 
Future research is needed to adequately quantify the time course of select 
physiological adaptations to altitude.  Additional performance measures at different time 
points would be beneficial in helping to reveal the interactions of the adaptations to hypoxia 
over time.  Although the current study summarizes the two primary strategies employed by 
athletes and coaches who have a short window in which to arrive at altitude, additional 
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research would give a more complete understanding to the mechanisms for acclimatization 
within this time frame.  Also, future studies could work to elucidate differences between 
individuals, such as magnitude of ventilatory changes, hematological differences, or 
desaturation.  Future studies could also be employed to determine the effects of 
acclimatization at shorter or longer time trial distances.  There may be differences in the short-
term acclimatization for more intense exercise, where a higher level of anaerobic energy is 
utilized.  With the increased interest in mountain running and ultra-marathons, studies on 
acclimatization for longer, lower intensity exercise would also be beneficial to the athletic and 
scientific communities. 
Summary 
In summary, the timing of arrival at altitude does not significantly affect endurance 
performance when the exposure begins less than 14 hours prior to the start of the competition.  
The longer duration of hypoxic exposure leads to greater plasma volume reductions although 
this did not seem to affect performance significantly.  The findings in this study will be 
valuable to athletes and coaches who are looking for a best practice recommendation for 
timing their arrival at altitude.  Athletes can choose the strategy that best fits in their schedules 
and seems the most logistically reasonable without significant effects on performance. 
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Appendices 
Appendix A – Data Set 
 
 
 
14hr_M
e
an_20k_P
ow
er
CTRL_M
e
an_4k_Po
w
er
CTRL_M
e
an_8k_Po
w
er
CTRL_M
e
an_12k_P
ow
er
CTRL_M
e
an_16k_P
ow
er
CTRL_M
e
an_20k_P
ow
er
Fam
_M
e
an_4k_Pe
rf
Fam
_M
e
an_8k_Pe
rf
Fam
_M
e
an_12k_P
erf
Fam
_M
e
an_16k_P
erf
Fam
_M
e
an_20k_P
erf
2hr_M
ea
n_4k_Per
f
2hr_M
ea
n_8k_Per
f
2hr_M
ea
n_2k_Per
f
2hr_M
ea
n_16k_Pe
rf
2hr_M
ea
n_20k_Pe
rf
244.61
252.75
256.98
235.51
232.22
272.76
6.891
6.781
6.767
6.825
6.710
7.321
7.148
7.082
7.113
6.858
192.99
207.22
194.42
197.74
202.40
223.05
6.546
6.763
7.220
7.209
6.660
7.450
7.402
7.549
7.499
7.260
197.65
212.90
203.62
205.70
214.61
226.72
6.563
6.761
6.771
6.886
6.870
7.094
7.280
7.177
7.317
7.297
237.15
265.50
263.86
260.99
257.21
286.43
6.103
6.177
6.282
6.281
6.119
6.689
6.795
6.870
6.987
6.897
208.36
203.32
191.92
188.96
182.29
212.67
6.814
7.203
7.318
7.282
6.908
7.437
7.385
7.414
7.358
7.092
248.63
268.46
260.02
259.06
254.85
280.30
6.568
6.423
6.371
6.245
6.139
6.668
6.671
6.696
6.701
6.510
139.95
219.75
192.81
198.16
183.26
185.86
6.992
7.177
7.124
7.017
6.938
7.450
7.790
7.968
8.205
8.137
191.18
171.41
181.22
185.28
183.21
205.49
6.960
6.932
7.019
6.980
6.899
7.539
7.409
7.544
7.215
7.243
158.20
162.57
164.19
165.76
168.67
188.78
7.785
7.635
7.629
7.595
7.455
8.137
8.152
8.160
8.356
7.871
207.58
192.79
196.91
211.78
204.64
221.82
7.368
7.248
7.057
7.142
6.979
7.846
7.708
7.609
7.584
7.340
14hr_D
iff
_Pow
er(F
am
)
CTRL_D
iff
_Pow
er(F
am
)
Fam
_M
e
an_4k_Po
w
er
Fam
_M
e
an_8k_Po
w
er
Fam
_M
e
an_12k_P
ow
er
Fam
_M
e
an_16k_P
ow
er
Fam
_M
e
an_20k_P
ow
er
2hr_M
ea
n_4k_Po
w
er
2hr_M
ea
n_8k_Po
w
er
2hr_M
ea
n_12k_Po
w
er
2hr_M
ea
n_16k_Po
w
er
2hr_M
ea
n_20k_Po
w
er
14hr_M
e
an_4k_Po
w
er
14hr_M
e
an_8k_Po
w
er
14hr_M
e
an_12k_P
ow
er
14hr_M
e
an_16k_P
ow
er
-0.10
-13.80
232.64
234.80
235.79
231.94
244.61
198.45
203.54
209.72
210.04
228.71
232.64
234.80
235.79
231.94
42.36
23.20
266.45
234.84
200.83
199.73
244.93
190.05
187.03
176.49
179.49
196.08
201.84
184.61
181.02
168.74
40.39
23.91
262.26
236.01
234.93
223.66
226.85
213.63
194.29
201.05
194.62
197.03
191.88
197.07
197.79
196.29
67.23
32.15
317.48
298.59
286.00
285.15
307.49
246.99
231.75
225.50
216.58
223.48
247.02
225.84
225.84
222.44
1.16
13.64
236.99
200.09
192.13
194.41
225.28
197.74
186.72
185.76
188.59
208.79
218.45
211.00
204.91
198.05
35.53
16.34
264.57
270.86
275.23
289.96
304.90
251.95
244.92
242.40
241.58
261.21
260.42
243.91
236.37
237.32
65.39
18.05
223.33
204.14
205.07
214.08
222.59
190.65
163.21
154.36
143.23
148.58
167.26
150.04
150.17
135.84
33.76
39.15
230.46
225.63
215.68
221.91
227.54
182.67
185.35
177.06
198.84
197.26
189.13
198.01
188.28
185.93
27.52
4.49
172.40
171.49
172.09
174.18
181.46
150.69
146.00
145.07
136.48
160.35
145.51
146.63
138.39
145.67
49.70
18.15
211.87
213.93
227.74
227.85
237.21
165.17
168.02
173.85
175.89
192.83
149.12
163.84
169.20
177.32
Subject
Vo2m
ax
Fam
_Perf
2hr_Perf
14hr_Per
f
Ctrl_Perf
2hr_D
iff_
Perf(Fam
)
14hr_D
iff
_Perf(Fa
m
)
Ctrl_D
iff_
Perf(Fam
)
2hr_D
iff_
Perf(CTRL
)
14hr_D
iff
_Perf(CT
RL)
Fam
_M
e
an_Pow
e
r
2hr_M
ea
n_Pow
er
14hr_M
e
an_Pow
e
r
Ctrl_M
ea
n_Pow
er
2hr_D
iff_
Pow
er(Fa
m
)
1
66.70
32.15
35.52
33.98
33.23
3.37
1.83
1.08
2.29
0.75
235.90
209.80
236.00
249.70
26.10
2
64.80
34.24
37.17
37.23
35.80
2.93
2.99
1.56
1.37
1.43
228.00
186.00
185.64
204.80
42.00
3
62.64
33.85
36.16
36.44
35.22
2.32
2.59
1.37
0.95
1.23
236.51
200.04
196.11
212.60
36.47
4
63.40
30.96
34.24
34.14
32.37
3.28
3.18
1.41
1.87
1.78
298.79
228.71
231.56
266.65
70.08
5
75.24
35.53
36.68
35.67
36.48
1.16
0.14
0.95
0.21
-0.81
209.26
193.39
208.10
195.62
15.87
6
63.32
31.75
33.25
33.38
32.42
1.50
1.63
0.68
0.83
0.96
280.78
248.34
245.24
264.44
32.44
7
67.41
36.02
39.55
40.69
36.43
3.53
4.66
0.40
3.12
4.26
213.75
159.44
148.36
195.70
54.31
8
74.04
34.79
36.95
36.81
37.22
2.16
2.02
2.43
-0.27
-0.41
224.23
188.08
190.47
185.07
36.14
9
58.52
38.10
40.52
40.76
38.47
2.42
2.66
0.37
2.05
2.29
174.29
147.57
146.76
169.79
26.71
10
69.55
34.62
38.09
38.35
35.79
3.47
3.73
1.17
2.29
2.56
223.54
174.95
173.84
205.39
48.59
61 
 
 
 
 
 
 
14hr_M
e
an_Ride_
SaO
2
Ctrl_M
ea
n_Ride_S
aO
2
2hr_H
our
1_Sleep_
SaO
2
2hr_H
our
2_Sleep_
SaO
2
2hr_H
our
3_Sleep_
SaO
2
2hr_H
our
4_Sleep_
SaO
2
2hr_H
our
5_Sleep_
SaO
2
2hr_H
our
6_Sleep_
SaO
2
2hr_H
our
7_Sleep_
SaO
2
2hr_H
our
8_Sleep_
SaO
2
2hr_H
our
9_Sleep_
SaO
2
2hr_H
our
10_Sleep
_SaO
2
2hr_H
our
11_Sleep
_SaO
2
2hr_H
our
12_Sleep
_SaO
2
2hr_H
our
13_Sleep
_SaO
2
2hr_H
our
14_Sleep
_SaO
2
92.27
97.73
98.56
98.78
98.74
97.64
98.12
97.80
97.84
97.57
97.68
98.03
97.41
97.67
96.03
94.94
90.90
98.06
98.39
97.31
98.34
98.52
98.64
98.78
98.79
98.89
98.83
98.88
98.88
98.88
97.26
96.23
81.96
95.54
97.99
97.89
98.75
98.65
98.29
97.15
97.87
97.74
98.29
97.53
97.71
98.75
98.75
96.44
84.75
92.75
98.13
96.33
95.78
98.77
98.71
98.70
98.07
98.39
98.71
98.32
98.62
97.13
96.81
95.84
94.15
97.60
97.58
98.80
96.70
98.11
98.81
98.71
98.35
98.47
98.62
98.91
98.39
98.50
98.46
96.32
85.82
98.01
93.43
93.67
94.33
94.12
93.72
93.50
93.33
93.67
93.61
93.12
93.28
93.15
90.12
84.44
92.95
95.21
98.16
97.39
96.92
98.41
97.86
96.69
98.45
98.67
98.48
98.37
98.15
98.54
96.43
94.53
95.96
97.69
97.84
97.56
97.38
96.61
96.01
96.38
96.19
97.23
97.05
97.24
97.20
97.62
96.34
94.84
89.05
94.07
97.20
97.38
98.34
98.68
98.45
98.17
98.94
97.55
97.99
98.80
97.37
97.35
94.64
93.68
88.04
93.71
98.87
98.75
98.09
98.22
98.98
98.81
98.47
96.94
96.16
96.55
96.40
96.65
96.98
95.23
2hr_M
ea
n_8k_VO
2
2hr_M
ea
n_12k_V
O
2
2hr_M
ea
n_16k_V
O
2
2hr_M
ea
n_20k_V
O
2
14hr_M
e
an_4k_V
O
2
14hr_M
e
an_8k_V
O
2
14hr_M
e
an_12k_V
O
2
14hr_M
e
an_16k_V
O
2
14hr_M
e
an_20k_V
O
2
CTRL_M
e
an_4k_V
O
2
CTRL_M
e
an_8k_V
O
2
CTRL_M
e
an_12k_V
O
2
CTRL_M
e
an_16k_V
O
2
CTRL_M
e
an_20k_V
O
2
Fam
_M
e
an_Ride_
SaO
2
2hr_M
ea
n_Ride_S
aO
2
39.91
40.67
40.96
44.75
44.91
48.74
48.81
48.64
49.54
44.36
50.28
47.21
44.87
49.30
90.00
47.52
45.68
46.08
49.24
42.71
43.75
43.68
42.56
44.40
43.21
46.32
47.41
46.98
49.25
96.70
88.20
38.11
39.16
39.68
39.87
37.42
39.79
40.74
41.42
43.05
43.56
43.66
44.93
47.64
50.17
85.19
48.94
47.04
45.13
44.70
41.95
43.07
42.99
43.39
44.93
51.92
51.11
51.28
47.18
45.33
97.09
88.47
47.98
47.07
47.01
51.17
42.04
44.30
43.62
42.24
44.30
41.40
42.73
43.86
41.64
47.11
97.67
90.58
52.81
52.37
53.62
55.94
57.24
58.88
57.31
57.75
62.60
52.12
55.66
55.54
55.76
61.06
96.26
88.49
38.40
36.16
34.61
35.47
33.47
32.48
34.33
31.82
32.96
34.59
36.10
37.01
35.80
35.65
97.01
96.33
43.65
42.81
46.32
47.06
35.85
43.15
44.76
44.77
43.14
32.87
38.53
39.87
40.50
44.46
96.56
92.66
38.92
39.66
39.09
43.15
33.02
35.90
37.47
41.07
46.02
34.94
37.82
38.97
41.12
46.02
94.29
88.87
47.15
49.86
51.04
54.76
47.86
53.54
56.43
58.64
68.74
50.09
55.88
58.75
59.02
61.76
95.72
89.55
14hr_M
e
an_4k_Pe
rf
14hr_M
e
an_8k_Pe
rf
14hr_M
e
an_12k_P
erf
14hr_M
e
an_16k_P
erf
14hr_M
e
an_20k_P
erf
CTRL_M
e
an_4k_Pe
rf
CTRL_M
e
an_8k_Pe
rf
CTRL_M
e
an_12k_P
erf
CTRL_M
e
an_16k_P
erf
CTRL_M
e
an_20k_P
erf
Fam
_M
e
an_4k_V
O
2
Fam
_M
e
an_8k_V
O
2
Fam
_M
e
an_12k_V
O
2
Fam
_M
e
an_16k_V
O
2
Fam
_M
e
an_20k_V
O
2
2hr_M
ea
n_4k_VO
2
6.891
6.782
6.767
6.825
6.709
6.667
6.548
6.762
6.818
6.432
51.94
51.84
51.57
53.69
55.47
37.10
7.267
7.434
7.502
7.681
7.345
7.193
7.276
7.232
7.176
6.918
50.88
53.84
49.28
47.00
51.72
43.84
7.399
7.236
7.233
7.284
7.291
7.095
7.148
7.116
6.997
6.862
50.56
53.20
52.05
50.15
48.97
36.83
6.720
6.864
6.874
6.915
6.771
6.541
6.469
6.502
6.564
6.292
51.57
56.16
54.04
53.44
55.35
45.29
7.092
7.069
7.143
7.260
7.106
7.234
7.325
7.381
7.486
7.054
54.86
51.67
49.20
49.50
54.65
45.76
6.580
6.665
6.749
6.749
6.635
6.508
6.501
6.518
6.561
6.333
52.61
58.60
60.56
65.68
69.97
49.85
7.796
8.061
8.066
8.419
8.344
7.014
7.315
7.246
7.441
7.411
41.63
45.11
44.68
47.25
49.46
37.27
7.436
7.234
7.378
7.409
7.358
7.735
7.478
7.414
7.444
7.149
43.92
50.28
50.08
52.54
53.82
39.36
8.248
8.126
8.330
8.153
7.898
7.892
7.771
7.743
7.694
7.370
37.65
43.00
44.34
45.41
46.66
36.22
8.152
7.805
7.688
7.562
7.144
7.368
7.248
7.057
7.142
6.979
50.63
55.73
58.28
59.63
62.61
42.73
62 
 
 
 
 
 
2hr_H
our
2_Sleep_
H
R
2hr_H
our
3_Sleep_
H
R
2hr_H
our
4_Sleep_
H
R
2hr_H
our
5_Sleep_
H
R
2hr_H
our
6_Sleep_
H
R
2hr_H
our
7_Sleep_
H
R
2hr_H
our
8_Sleep_
H
R
2hr_H
our
9_Sleep_
H
R
2hr_H
our
10_Sleep
_H
R
2hr_H
our
11_Sleep
_H
R
2hr_H
our
12_Sleep
_H
R
2hr_H
our
13_Sleep
_H
R
2hr_H
our
14_Sleep
_H
R
14hr_H
o
ur1_Slee
p_H
R
14hr_H
o
ur2_Slee
p_H
R
14hr_H
o
ur3_Slee
p_H
R
53.00
50.54
50.03
49.75
47.90
49.41
48.00
46.82
45.15
46.66
49.28
57.59
65.43
64.17
65.87
60.45
60.48
51.05
53.10
45.30
43.65
43.84
40.26
41.87
41.25
42.20
40.63
53.15
51.28
74.13
72.59
73.49
85.40
64.49
66.15
69.31
64.25
62.26
56.92
65.69
68.04
64.38
65.39
63.68
69.43
76.76
70.32
73.45
63.41
64.43
60.25
52.04
53.08
54.63
50.07
55.28
45.96
49.31
66.13
57.36
68.64
68.58
64.45
64.12
62.93
63.42
64.88
62.38
58.91
51.46
51.07
49.42
46.58
47.66
49.60
53.14
57.79
70.03
54.24
64.67
66.51
66.02
65.22
57.82
55.20
55.82
48.92
49.08
47.28
52.39
53.19
54.90
61.37
78.60
76.82
73.07
62.95
66.26
62.52
58.07
55.15
43.75
41.34
39.52
39.86
38.92
39.83
49.22
49.15
68.53
65.54
68.46
71.67
63.62
54.28
46.03
53.59
45.60
46.33
46.19
42.99
46.69
46.09
52.30
57.82
73.73
66.18
67.98
63.51
45.32
43.42
40.99
42.93
41.93
37.76
41.91
37.21
52.13
64.98
60.10
61.22
65.09
65.39
51.08
65.69
67.01
62.79
55.13
52.15
52.51
48.94
42.10
42.92
43.00
41.93
44.94
47.45
69.41
65.91
73.65
CTRL_H
o
ur1_Slee
p_SaO
2
CTRL_H
o
ur2_Slee
p_SaO
2
CTRL_H
o
ur3_Slee
p_SaO
2
CTRL_H
o
ur4_Slee
p_SaO
2
CTRL_H
o
ur5_Slee
p_SaO
2
CTRL_H
o
ur6_Slee
p_SaO
2
CTRL_H
o
ur7_Slee
p_SaO
2
CTRL_H
o
ur8_Slee
p_SaO
2
CTRL_H
o
ur9_Slee
p_SaO
2
CTRL_H
o
ur10_Sle
ep_SaO
2
CTRL_H
o
ur11_Sle
ep_SaO
2
CTRL_H
o
ur12_Sle
ep_SaO
2
CTRL_H
o
ur13_Sle
ep_SaO
2
CTRL_H
o
ur14_Sle
ep_SaO
2
CTRL
2hr_H
our
1_Sleep_
H
R
98.32
98.37
98.15
98.57
96.33
97.41
97.70
97.62
97.42
96.51
96.70
96.55
98.72
98.79
97.65
66.80
98.87
98.87
98.54
98.45
98.19
97.98
98.51
98.10
98.32
98.55
98.57
98.78
98.69
98.59
98.50
71.31
98.13
98.46
98.25
98.28
97.12
97.11
97.94
98.15
98.14
98.05
98.49
98.43
98.72
97.99
98.09
78.18
98.22
98.73
98.59
98.52
98.99
98.99
99.00
99.00
98.99
98.94
98.83
98.75
98.83
98.26
98.76
66.19
98.03
96.34
96.25
97.56
98.80
98.10
98.06
98.77
98.13
98.60
98.94
98.64
97.58
97.39
97.94
64.65
98.74
98.47
97.79
98.78
98.10
97.81
97.90
97.70
98.06
97.63
97.76
97.51
94.67
96.43
97.67
69.50
98.47
97.95
98.13
97.93
98.29
98.40
98.25
98.41
98.48
98.66
98.76
98.56
97.92
98.15
98.31
68.77
97.95
97.49
97.10
97.22
97.44
96.96
96.71
96.79
96.91
96.98
96.83
97.36
98.62
98.39
97.34
72.68
98.44
97.19
98.09
98.26
97.95
98.05
98.26
98.65
98.00
97.48
92.79
98.32
97.68
97.15
97.59
62.33
98.69
98.96
97.79
98.34
98.85
98.72
97.57
97.01
96.87
97.03
97.58
97.53
97.98
98.34
97.95
67.76
2hr
14hr_H
o
ur1_Slee
p_SaO
2
14hr_H
o
ur2_Slee
p_SaO
2
14hr_H
o
ur3_Slee
p_SaO
2
14hr_H
o
ur4_Slee
p_SaO
2
14hr_H
o
ur5_Slee
p_SaO
2
14hr_H
o
ur6_Slee
p_SaO
2
14hr_H
o
ur7_Slee
p_SaO
2
14hr_H
o
ur8_Slee
p_SaO
2
14hr_H
o
ur9_Slee
p_SaO
2
14hr_H
o
ur10_Sle
ep_SaO
2
14hr_H
o
ur11_Sle
ep_SaO
2
14hr_H
o
ur12_Sle
ep_SaO
2
14hr_H
o
ur13_Sle
ep_SaO
2
14hr_H
o
ur14_Sle
ep_SaO
2
14hr
97.63
96.97
95.15
95.12
94.43
93.79
93.57
92.46
93.39
94.39
94.05
95.84
97.72
96.66
97.21
95.05
98.33
94.31
94.49
93.78
94.08
93.92
94.67
94.67
94.21
94.65
94.80
94.54
94.76
96.84
97.16
94.78
97.99
93.20
93.62
95.06
94.56
94.21
92.93
93.20
94.00
93.59
94.26
94.35
95.17
95.85
96.43
94.32
97.74
93.31
97.97
97.01
92.60
94.81
95.58
97.36
98.37
98.67
95.63
94.63
96.72
96.73
96.77
96.15
98.19
92.84
94.18
96.01
96.14
97.27
95.65
96.47
96.83
96.20
95.18
94.68
95.05
96.45
93.82
95.48
92.68
98.12
97.39
96.84
97.15
97.04
97.58
97.45
97.40
98.05
98.64
98.43
98.01
94.99
91.28
97.03
97.65
94.49
95.37
95.18
95.22
95.91
94.50
94.56
94.37
94.57
94.76
95.06
95.62
95.71
94.43
94.98
96.82
95.56
96.16
95.85
95.59
95.73
93.74
94.71
96.98
93.33
94.60
94.60
94.20
95.19
96.19
95.17
97.47
93.27
92.63
89.58
90.70
92.99
93.23
93.15
94.28
94.26
94.72
94.96
92.44
94.96
95.51
93.33
97.51
95.49
94.78
95.20
93.83
92.37
91.59
92.05
92.00
92.77
92.75
93.20
93.21
94.60
95.17
93.50
63 
 
 
 
 
 
 
CTRL_M
ea
n_Activity
_Counts
Fam
_M
e
an_H
R
2hr_M
ea
n_H
R
14hr_M
e
an_H
R
CTRL_M
e
an_H
R
2hr_Chan
gePV_(Pr
eRide)
2hr_Chan
gePV_(Po
stRide)
14hr_Cha
ngePV_(P
reRide)
14hr_Cha
ngePV_(P
ostRide)
CTRL_Ch
angePV_(
PreRide)
CTRL_Ch
angePV_(
PostRide)
2hr_BV_
N
ight
14hr_BV_
N
ight
CTRL_BV
_N
ight
FAM
_VE/
VO
2
813.1
169.2
169
165.2
170.2
372
342
556
861
275
630
7049
7309
6802
281
26.51
750.5
180.4
166.2
168.2
174.6
170
443
630
841
324
695
6296
7051
7379
306.0465
32.20
755.1
186.6
183.2
181.4
179.0
137
228
295
492
376
537
6397
6805
6068
-80.5012
28.06
757.8
186.0
182.4
178.2
179.2
305
830
878
988
515
617
8110
8391
7269
362.9718
24.39
732.5
158.2
155.0
159.0
145.2
330
372
509
722
163
381
5812
6185
5999
345.6511
24.06
710.6
176.2
171.0
173.4
172.8
308
346
662
871
438
994
6978
6787
7003
224.2138
28.08
759.1
174.8
156.0
140.4
158.6
392
452
361
381
172
219
6406
6203
5632
188.815
44.85
719.9
168.8
156
167.2
151.8
204
240
452
483
265
427
6984
6309
6676
187.5373
33.23
754.3
172
161.8
161
151.4
510
918
520
629
226
686
7028
5805
7107
293.5298
33.40
770.2
172.6
175.4
174.2
177.8
444
552
437
631
195
471
5573
5732
5351
241.5355
39.04
CTRL_H
o
ur6_Slee
p_H
R
CTRL_H
o
ur7_Slee
p_H
R
CTRL_H
o
ur8_Slee
p_H
R
CTRL_H
o
ur9_Slee
p_H
R
CTRL_H
o
ur10_Sle
ep_H
R
CTRL_H
o
ur11_Sle
ep_H
R
CTRL_H
o
ur12_Sle
ep_H
R
CTRL_H
o
ur13_Sle
ep_H
R
CTRL_H
o
ur14_Sle
ep_H
R
2hr_M
in
ute_ETC
O
2
14hr_M
in
ute_ETC
O
2
CTRL_M
i
nute_ETC
O
2
2hr_ETC
O
2diff_C
TRL
14hr_ETC
O
2diff_C
TRL
2hr_M
ea
n_Activity
_Counts
14hr_M
ea
n_Activity
_Counts
45.91
49.27
48.88
42.95
45.53
46.38
56.27
47.80
58.31
791.0
738.1
47.05
48.12
49.51
47.68
42.57
41.46
47.96
54.53
58.19
4.42
4.70
5.42
1.00
0.72
722.9
698.5
49.44
51.23
47.25
44.19
49.91
45.12
48.83
51.24
59.94
4.85
4.93
4.54
-0.32
-0.40
718.9
730.7
51.30
51.99
49.40
46.34
48.44
48.34
45.46
46.67
58.47
4.90
4.89
5.23
0.33
0.34
735.5
731.6
49.71
46.82
48.29
45.97
49.67
47.99
48.12
50.99
52.46
5.01
4.65
5.27
0.26
0.62
717.1
718.6
46.86
50.62
46.39
44.70
43.59
41.64
44.81
48.30
54.09
5.58
5.41
5.58
0.00
0.17
745.7
719.0
56.04
44.91
42.72
41.55
40.87
42.52
43.51
48.28
49.88
4.71
4.16
5.11
0.40
0.94
761.2
760.2
50.46
44.79
43.59
44.28
44.50
43.39
47.44
47.81
52.16
4.75
4.63
5.12
0.37
0.49
705.7
771.1
40.32
43.42
41.82
40.92
41.39
61.55
61.17
60.58
59.24
3.72
3.46
4.07
0.36
0.61
790.2
809.7
51.64
48.52
45.26
43.34
42.77
41.66
42.60
46.38
49.27
5.00
4.21
5.07
0.07
0.85
758.6
731.6
14hr_H
o
ur4_Slee
p_H
R
14hr_H
o
ur5_Slee
p_H
R
14hr_H
o
ur6_Slee
p_H
R
14hr_H
o
ur7_Slee
p_H
R
14hr_H
o
ur8_Slee
p_H
R
14hr_H
o
ur9_Slee
p_H
R
14hr_H
o
ur10_Sle
ep_H
R
14hr_H
o
ur11_Sle
ep_H
R
14hr_H
o
ur12_Sle
ep_H
R
14hr_H
o
ur13_Sle
ep_H
R
14hr_H
o
ur14_Sle
ep_H
R
CTRL_H
o
ur1_Slee
p_H
R
CTRL_H
o
ur2_Slee
p_H
R
CTRL_H
o
ur3_Slee
p_H
R
CTRL_H
o
ur4_Slee
p_H
R
CTRL_H
o
ur5_Slee
p_H
R
52.25
52.57
46.43
49.35
51.11
53.81
50.71
52.74
51.74
65.51
74.39
51.55
57.81
53.69
48.24
56.96
69.46
66.21
64.27
62.77
63.67
62.94
64.85
67.01
71.22
62.13
64.35
67.92
65.18
64.05
54.02
47.13
71.93
71.69
74.52
68.77
59.44
57.23
60.74
58.65
48.44
56.88
58.06
75.48
68.12
61.25
59.65
55.14
65.52
67.86
58.36
55.21
55.05
53.74
51.56
53.60
53.78
54.56
65.64
63.76
58.34
65.44
58.19
51.83
68.53
61.21
59.89
58.14
50.66
48.96
52.24
49.97
52.04
55.33
53.76
53.27
54.82
56.26
54.44
55.36
70.41
63.28
66.00
57.90
56.10
51.23
53.37
48.87
53.46
60.06
65.05
65.04
59.50
56.14
55.18
51.07
66.69
70.29
55.28
49.95
49.08
47.77
46.24
48.11
50.91
46.19
54.23
70.24
67.40
65.75
71.71
69.84
70.22
69.92
62.11
59.66
45.63
47.26
45.76
46.40
50.01
51.38
56.58
66.69
64.95
68.31
59.98
58.74
43.31
41.45
42.19
45.83
43.35
41.09
41.68
43.21
66.97
68.82
73.76
58.08
62.80
48.64
44.56
43.72
54.00
53.06
54.39
47.42
45.12
47.18
43.58
43.50
43.79
50.19
45.78
71.10
63.85
58.33
59.52
52.95
64 
 
 
 
 
 
CTRL_M
a
ss_Pre
2hr_M
as
s_Post
14hr_M
a
ss_Post
CTRL_M
a
ss_Post
2hr_U
rin
e_Volum
e
14hr_Vol
um
e_Voi
ded
CTRL_Vol
um
e_Voi
ded
FAM
_4k_
RPE
2hr_4k_R
PE
14hr_4k_
RPE
CTRL_4k_
RPE
FAM
_8k_
RPE
2hr_8k_R
PE
14hr_8k_
RPE
CTRL_8k_
RPE
FAM
_12k
_RPE
73.36
72.73
73.22
72.25
1630
1660
1800
11
13
13
13
13
14
14
14
14
69.60
67.70
68.25
68.99
1375
3790
1500
15
14
14
14
16
15
15
14
17
73.09
72.84
72.34
72.22
1675
1875
1275
15
13
13
12
16
15
15
14
17
84.92
83.83
83.28
84.25
4200
3925
2700
12
12
13
13
15
15
15
15
16
63.84
63.82
64.24
63.32
1575
2325
1975
14
13
14
13
14
14
14
14
14
68.94
70.07
69.21
67.92
1500
1475
1050
12
12
12
12
13
13
13
13
14
68.16
67.07
68.55
68.08
3550
2675
2725
15
16
17
17
17
17
18
17
18
71.18
70.80
71.19
70.38
1050
1450
825
13
12
11
12
14
13
12
12
15
65.48
63.98
63.93
64.70
3050
3440
2820
12
13
16
13
13
14
17
13
15
55.52
54.08
55.20
54.92
1825
1600
2225
13
14
13
13
14
15
13
14
14
2hr_U
SG
14hr_U
S
G
CTRL_U
S
G
2hr_PV
14hr_PV
CTRL_PV
2hr_PV_p
re_ride
2hr_PV_p
ost_ride
14hr_PV_
pre_ride
14hr_PV_
post_ride
CTRL_PV_
pre_ride
CTRL_PV_
post_ride
2hr_M
as
s_N
ight
14hr_M
a
ss_N
ight
CTRL_M
a
ss_N
ight
2hr_M
as
s_Pre
14hr_M
a
ss_Pre
1.0014
1.0031
1.0023
3648
4166
3758
3401
3306
3610
3305
3483
3128
75.45
75.88
75.33
73.65
74.07
1.0057
1.0040
1.0078
3432
3872
4182
3262
2989
3242
3032
3858
3486
68.83
73.14
71.85
68.35
69.17
1.0009
1.0014
1.0009
3346
3659
3226
3209
3117
3365
3168
2851
2689
75.43
75.60
74.94
73.44
73.14
1.0057
1.0018
1.0049
4338
4938
4452
4034
3508
4060
3950
3937
3835
88.25
88.95
86.57
84.80
85.20
1.0096
1.0081
1.0092
3185
3398
3312
2855
2814
2859
2676
3148
2931
65.32
66.77
65.35
64.48
64.80
1.0083
1.0074
1.0005
3922
3849
4107
3613
3575
3187
2977
3669
3113
71.50
71.09
69.28
70.88
70.10
1.0095
1.0095
1.0053
3423
3257
2938
3029
2971
2896
2876
2766
2719
69.66
69.03
70.11
67.36
68.90
1.0098
1.0092
1.0036
3634
3128
3500
3426
3387
2675
2644
3235
3073
71.51
72.10
71.32
71.55
71.80
1.0057
1.0057
1.0044
4149
3611
3959
3640
3231
3092
2982
3733
3273
66.80
67.07
68.05
65.20
64.51
1.0036
1.0005
1.0092
3232
3348
3131
2789
2681
2912
2717
2936
2660
56.30
56.58
57.75
54.60
55.73
2hr_VE/V
O
2
14hr_VE/
VO
2
CTRL_VE/
VO
2
2hr_VE/V
O
2diff
14hr_VE/
VO
2diff
CTRL_VE/
VO
2diff
2hr_M
ea
n_FiO
2
14hr_M
e
an_FiO
2
CTRL_M
e
an_FiO
2
2hr_Last
hour_M
e
an_FiO
2
2hr_M
ea
n_Tem
p
14hr_M
e
an_Tem
p
CTRL_M
e
an_Tem
p
2hr_M
ea
n_RideFi
O
2
14hr_M
e
an_RideFi
O
2
CTRL_M
e
an_RideFi
O
2
27.01
28.66
25.53
1.48
2.15
-0.98
15.84
16.23
20.39
15.87
20.47
20.48
20.60
16.22
16.25
20.97
31.39
33.09
33.89
-0.81
0.89
1.69
16.52
16.21
20.32
16.39
20.44
21.12
20.30
16.16
16.21
20.69
31.73
29.31
27.28
3.67
1.25
-0.78
16.47
16.16
20.41
16.44
20.56
20.52
20.61
16.15
16.23
20.95
33.44
27.10
22.78
9.05
2.71
-1.62
16.26
15.85
20.12
16.26
20.28
19.74
20.36
16.22
16.20
20.84
29.47
37.67
28.71
5.41
13.61
4.65
16.11
15.82
20.01
16.11
19.79
19.86
19.86
16.21
16.22
20.62
32.01
31.41
28.21
3.94
3.33
0.13
16.02
15.98
20.32
16.02
19.83
19.77
20.17
16.24
16.21
20.66
41.92
40.29
44.29
-2.92
-4.56
-0.55
16.18
15.95
20.02
16.21
20.19
19.84
20.18
16.20
16.18
20.40
31.42
32.53
28.75
-1.81
-0.70
-4.48
16.29
15.90
19.99
16.29
19.83
19.97
19.84
16.19
16.19
20.64
41.35
38.05
35.11
7.96
4.66
1.72
16.18
16.17
20.19
16.19
20.62
20.57
20.35
16.16
16.19
20.67
38.08
30.95
32.72
-0.96
-8.09
-6.32
16.14
15.99
20.18
16.14
19.90
19.79
19.82
16.19
16.24
20.76
65 
 
 
 
 
 
 
2hr_4k_H
R
14hr_4k_
H
R
CTRL_4k_
H
R
FAM
_8k_
H
R
2hr_8k_H
R
14hr_8k_
H
R
CTRL_8k_
H
R
FAM
_12k
_H
R
2hr_12k_
H
R
14hr_12k
_H
R
CTRL_12k
_H
R
FAM
_16k
_H
R
2hr_16k_
H
R
14hr_16k
_H
R
CTRL_16k
_H
R
FAM
_20k
_H
R
157
161
166
161
161
161
167
168
175
165
161
170
173
163
167
185
160
162
168
183
156
169
171
176
165
165
174
179
169
170
176
184
179
172
173
186
181
178
174
186
184
180
176
185
181
184
182
192
179
171
169
185
181
174
177
185
181
177
180
184
182
180
179
196
157
160
141
156
152
157
143
151
150
156
142
148
150
156
139
173
167
170
167
163
166
172
169
176
169
170
171
183
170
175
174
192
157
141
155
167
154
144
152
174
154
137
161
179
152
129
156
189
154
164
147
168
157
164
146
169
152
169
150
170
157
166
152
175
155
142
139
165
158
147
144
171
159
159
148
177
160
171
153
186
166
167
172
167
173
170
172
170
179
172
180
176
179
176
181
190
2hr_8k_D
yspnea
14hr_8k_
D
yspnea
CTRL_8k_
D
yspnea
FAM
_12k
_D
yspne
a
2hr_12k_
D
yspnea
14hr_12k
_D
yspne
a
CTRL_12k
_D
yspne
a
FAM
_16k
_D
yspne
a
2hr_16k_
D
yspnea
14hr_16k
_D
yspne
a
CTRL_16k
_D
yspne
a
FAM
_20k
_D
yspne
a
2hr_20k_
D
yspnea
14hr_20k
_D
yspne
a
CTRL_20k
_D
yspne
a
FAM
_4k_
H
R
4
4
4
4
5
5
4
5
7
6
5
9
10
7
10
162
6
5
4
5
7
6
5
6
8
8
6
8
9
9
7
180
6
6
4
7
8
7
5
8
8
8
7
9
9
10
10
184
6
7
6
7
7
7
7
8
7
8
8
10
9
9
10
180
2
4
2
3
2
4
2
3
3
4
3
4
5
5
4
163
2
2
2
3
2
3
3
4
2
4
3
9
9
9
9
167
3
2
2
3
4
2
2
5
5
2
2
7
5
2
2
165
3
3
2
5
3
4
3
7
4
4
4
7
4
5
6
162
4
2
3
4
4
3
4
5
4
4
4
7
6
5
7
161
4
4
4
4
4
4
5
5
5
5
5
6
7
8
8
160
2hr_12k_
RPE
14hr_12k
_RPE
CTRL_12k
_RPE
FAM
_16k
_RPE
2hr_16k_
RPE
14hr_16k
_RPE
CTRL_16k
_RPE
FAM
_20k
_RPE
2hr_20k_
RPE
14hr_20k
_RPE
CTRL_20k
_RPE
FAM
_4k_
D
yspnea
2hr_4k_D
yspnea
14hr_4k_
D
yspnea
CTRL_4k_
D
yspnea
FAM
_8k_
D
yspnea
15
15
15
16
16
17
15
19
20
19
20
2
3
3
2
4
17
17
16
17
17
17
17
19
19
19
17
3
6
4
3
4
17
17
14
18
18
18
17
19
20
19
19
4
4
4
3
6
16
16
17
17
17
18
18
20
19
19
19
3
4
5
4
5
14
14
14
15
14
14
15
15
16
15
16
3
2
3
2
3
14
14
14
15
14
15
15
20
20
20
20
2
2
2
3
2
18
18
18
18
18
19
19
20
19
20
19
3
2
1
2
3
13
14
13
16
14
14
15
17
15
15
16
2
2
2
2
4
15
16
14
16
16
19
15
19
20
20
20
3
3
2
2
3
16
14
15
16
16
15
16
18
17
18
17
3
3
3
3
3
66 
 
 
 
 
 
 
CTRL_VE_
8k
CTRL_VE_
12k
CTRL_VE_
16k
CTRL_VE_
20k
2hr_VE/V
O
2_4k
2hr_VE/V
O
2_8k
2hr_VE/V
O
2_12k
2hr_VE/V
O
2_16k
2hr_VE/V
O
2_20k
14hr_VE/
VO
2_4k
14hr_VE/
VO
2_8k
14hr_VE/
VO
2_12k
14hr_VE/
VO
2_16k
14hr_VE/
VO
2_20k
CTRL_VE/
VO
2_4k
CTRL_VE/
VO
2_8k
70.88
67.66
67.67
111.18
24.85
26.31
28.70
28.42
29.19
21.84
22.22
23.58
22.44
24.55
25.13
25.81
87.74
90.45
95
125.88
31.13
31.27
30.55
30.22
34.20
34.24
33.82
34.10
32.12
38.42
33.76
33.47
69.12
68.93
72.73
102.12
32.82
31.69
30.90
30.34
32.00
28.80
28.34
30.55
31.15
31.16
25.43
25.94
96.13
95.32
89.08
113.68
32.22
33.60
33.70
32.22
35.00
27.30
26.82
26.53
26.98
28.81
22.24
22.26
66.21
61.03
59.63
83.55
31.47
28.14
27.77
27.51
32.08
42.61
39.12
38.50
34.76
37.96
31.23
30.79
87.6
91.31
87.8
116.56
32.18
31.67
31.98
31.56
36.38
29.64
30.58
30.89
30.79
38.84
27.66
27.72
79.94
22.8575
75.07
89.39
49.49
41.03
41.29
36.87
38.50
38.98
42.00
39.53
39.73
40.00
50.53
42.08
64.54
66.44
70.79
88.72
30.54
31.48
30.38
32.87
32.94
30.81
32.61
33.19
33.73
34.02
28.02
28.07
72.59
72.23
78.66
104.93
42.43
41.70
42.49
39.90
46.82
37.15
36.82
38.68
39.69
42.20
33.97
35.87
78.25
88.14
89.6
107.15
36.89
37.02
40.38
39.57
42.10
30.73
29.54
31.67
32.76
33.19
33.20
31.54
CTRL_ETC
O
2_4k
CTRL_ETC
O
2_8k
CTRL_ETC
O
2_12k
CTRL_ETC
O
2_16k
CTRL_ETC
O
2_20k
2hr_VE_4
k
2hr_VE_8
k
2hr_VE_1
2k
2hr_VE_1
6k
2hr_VE_2
0k
14hr_VE_
4k
14hr_VE_
8k
14hr_VE_
12k
14hr_VE_
16k
14hr_VE_
20k
CTRL_VE_
4k
60.15
62.86
76.7
72.58
82.57
67.18
67.08
70.68
66.27
83.69
73.09
84.24
78.25
78.55
78.9
98.67
84.06
77.1
81.31
74.73
97.97
90.14
3.85
3.36
3.60
4.22
4.03
77.85
72.01
74.63
70.81
81.59
66.92
67.4
76.93
80.27
86.01
69.43
4.80
4.60
4.36
4.33
3.81
109.57
109.44
104.65
98
113.96
102.61
99
98.43
104.42
123.06
94.76
4.77
4.72
4.73
4.87
4.44
81.4
70.31
68.49
68.72
92.3
103.86
88.11
85.06
74.09
93.24
67.53
5.15
5.22
4.98
5.07
4.16
98.91
93.75
96.49
94.73
125.75
102.66
99.13
102.32
103.72
147.52
82.96
3.34
3.65
3.52
3.65
3.46
102.8
79.33
81.82
67.45
79.3
72.01
79.38
68.31
69.44
75.85
102.99
5.17
5.06
4.78
4.63
4.32
74.25
77.32
72.48
90.45
90.49
73.21
81.97
86.62
86.11
92.66
57.13
4.03
3.51
3.52
3.55
3.55
86.05
85.28
88.91
85.42
116.06
65.69
70.5
78.46
89.82
107.89
67.11
4.23
4.44
3.84
3.61
3.46
76.28
79.24
93.26
88.51
114.67
75.82
74.05
77.42
94.5
113.13
82.83
2hr_20k_
H
R
14hr_20k
_H
R
CTRL_20k
_H
R
2hr_Surv
ey
14hr_Sur
vey
CTRL_Sur
vey
2hr_ETC
O
2_4k
2hr_ETC
O
2_8k
2hr_ETC
O
2_12k
2hr_ETC
O
2_16k
2hr_ETC
O
2_20k
14hr_ETC
O
2_4k
14hr_ETC
O
2_8k
14hr_ETC
O
2_12k
14hr_ETC
O
2_16k
14hr_ETC
O
2_20k
179
176
190
2
0
1
181
175
184
2
6
7
191
193
190
4
5
7
4.53
4.42
4.38
4.33
4.28
5.06
4.86
4.43
4.05
4.34
189
189
191
3
2
1
4.05
3.76
3.74
3.80
3.52
3.79
3.65
3.72
3.53
3.28
166
166
161
4.00
4.55
4.78
4.69
3.77
3.58
3.82
3.84
4.14
3.68
183
180
188
4.45
4.42
4.27
4.13
3.44
4.29
4.19
4.10
4.04
3.30
163
151
169
10
3
3
3.37
3.38
3.57
3.59
3.58
3.58
3.75
3.67
3.79
3.55
160
173
164
4
9
5
4.49
4.08
4.15
3.69
3.55
4.46
3.99
3.88
3.81
3.57
177
186
173
10
12
4
3.24
3.32
3.72
3.60
3.41
3.73
3.74
3.38
3.31
3.19
181
186
184
9
3
4
3.57
3.34
3.51
3.53
3.51
3.73
3.72
3.5
3.35
3.19
67 
 
 
 
 
 
 
2hr SaO
2 
16k
2hr SaO
2 
20k
14hr 
SaO
2 4k
14hr 
SaO
2 8k
14hr 
SaO
2 12k
14hr 
SaO
2 16k
14hr 
SaO
2 20k
CTRL 
SaO
2 4k
CTRL 
SaO
2 8k
CTRL 
SaO
2 12k
CTRL 
SaO
2 16k
CTRL 
SaO
2 20k
89.59
88.04
94.15385
93.69231
92.07692
91.30769
89.47368
98.5
97.41935
97.46154
97.14474
97.45161
89.66667
87.09524
90.74473
90.03667
89.15333
92.71667
91.85
98.3975
98.21
98.3275
97.6275
97.5075
85.465
86.2925
82.2275
80.6975
81.445
81.8425
83.1375
95.845
96.33
95.0725
95.0375
95.2225
88.4475
89.8025
84.0075
84.2725
84.605
85.1025
86.01
91.8025
96.76
96.435
92.8125
84.99
89.2925
89.6775
94.7625
93.405
94.07
94.4275
94.54
97.3275
97.295
97.445
97.425
83.4425
88.6825
88.4975
88.965
87.01
87.9775
88.3025
92.1525
96.52
98.355
99.5625
99.3475
99.7075
96.0625
96.9075
94.97
93.585
92.7825
91.6975
90.0325
94.1425
94.8775
98.405
98.205
98.11
92
92.01
90.86
90.4675
91.945
91.5225
92.9675
97.6525
98.26
97.42
97.605
97.835
88.8975
89.535
88.395
88.5975
89.66
89.035
88.595
94.2625
94.4025
94.275
93.52
93.75
88.7825
87.765
88.41
87.965
90.0775
89.6125
90.15
96.32
95.135
97.7075
95.02
97.675
2hr_VE/V
CO
2_8k
2hr_VE/V
CO
2_12k
2hr_VE/V
CO
2_16k
2hr_VE/V
CO
2_20k
14hr_VE/
VCO
2_4k
14hr_VE/
VCO
2_8k
14hr_VE/
VCO
2_12
k
14hr_VE/
VCO
2_16
k
14hr_VE/
VCO
2_20
k
CTRL_VE/
VCO
2_4k
CTRL_VE/
VCO
2_8k
CTRL_VE/
VCO
2_12
k
CTRL_VE/
VCO
2_16
k
CTRL_VE/
VCO
2_20
k
2hr SaO
2 
4k
2hr SaO
2 
8k
2hr SaO
2 
12k
28.43
28.43
30.36
30.99
26.72
27.20
29.71
29.58
30.35
20.37
21.73
22.12
21.85
23.59
88.38
88.45
90.14
36.34
34.85
34.52
36.24
36.10
39.43
39.31
39.45
44.33
30.40
31.90
33.17
32.55
37.21
88.82143
87.76667
90.45833
31.41
31.03
31.55
32.21
31.19
31.65
33.21
34.88
33.85
27.84
28.66
28.18
29.15
33.18
83.2625
85.2875
85.0875
36.85
37.68
36.88
37.56
36.35
36.70
36.60
37.84
38.89
30.38
30.92
32.73
33.01
34.59
87.95
87.3875
88.555
33.04
32.55
32.55
37.05
39.72
38.57
38.76
36.69
38.95
32.25
32.42
32.16
31.05
31.59
91.825
90.32
90.3575
32.46
33.32
33.87
36.14
33.60
34.63
35.26
35.87
45.39
28.26
28.41
29.07
28.26
31.80
88.07
87.9775
87.65
46.11
45.89
44.85
45.73
42.51
46.13
45.81
46.85
47.99
37.57
40.32
43.91
41.71
41.83
95.6775
96.4675
95.975
36.54
36.64
39.13
40.22
33.89
37.24
37.83
38.75
39.18
30.36
30.78
32.17
31.90
33.02
93.5675
94.5075
91.8875
46.66
47.61
47.38
47.56
43.03
43.56
46.39
47.51
50.96
38.19
40.09
39.89
40.73
42.87
88.5425
88.49
88.765
40.36
44.85
46.09
44.24
39.92
38.68
44.80
45.99
46.50
33.74
32.71
35.04
36.48
37.54
88.515
91.1425
90.1925
CTRL_VE/
VO
2_12k
CTRL_VE/
VO
2_16k
CTRL_VE/
VO
2_20k
Age
Starting 
W
eight
Baseline 
H
CT
Baseline 
H
b
2hr PV
14hr PV
CTRL PV
2hr Ride 
Tem
p
14hr Ride 
Tem
p
CTRL Ride 
Tem
p
2hr_VE/V
CO
2
14hr_VE/
VCO
2
CTRL_VE/
VCO
2
2hr_VE/V
CO
2_4k
24.98
25.01
32.54
26.00
74.50
45.0
1018
3648
3610
3757
21.8
21.0
22.0
28.68
28.66
21.61
26.53
34.79
34.77
43.70
21.00
69.05
43.3
1018
3431
4080
4181
21.2
22.0
21.2
35.03
38.76
32.12
33.78
25.56
25.92
31.47
19.00
74.56
46.8
922
3345
3772
3226
22.0
21.9
21.0
31.42
32.60
29.49
30.43
23.09
22.40
24.87
20.00
86.17
42.0
1036
4338
4881
4452
20.4
19.0
21.2
36.47
36.76
32.07
34.92
28.37
26.76
29.62
23.00
68.62
44.8
888
3185
3398
3312
19.0
19.4
19.0
33.83
37.33
31.30
35.84
28.92
27.54
33.02
21.00
68.90
41.4
1071
3922
3849
4107
19.0
19.1
20.3
32.65
35.17
28.56
31.94
45.23
39.96
42.12
25.00
68.68
47.7
831
3420
3257
2938
20.2
18.8
21.0
45.34
45.27
41.59
47.83
28.86
28.01
30.21
20.00
71.97
47.6
1108
3634
3128
3500
19.0
19.0
18.9
36.41
36.84
31.47
34.13
35.29
34.49
38.96
34.00
65.88
38.3
995
4451
3611
4384
22.0
22.0
21.6
46.64
45.78
39.95
46.11
32.91
34.05
36.51
25.00
55.50
42.6
787
3233
3349
3072
19.0
18.0
19.0
42.21
41.71
34.39
39.66
68 
 
Appendix B 
The Groningen Sleep Quality Score (GSQS, 17) 
 
Source: Meijman TF, de Vries-Griever AH, de Vries G. The evaluation of the Groningen Sleep Quality Scale. 
Groningen: Heymans Bulletin (HB 88-13-EX), 1988 
Instructions:  Please circle “True” or “False” to the following statements 
 
1. I had a deep sleep last night      True  False 
 
2. I feel that I slept poorly last night     True  False 
 
3. It took me more than half an hour to fall asleep last night  True  False 
 
4. I woke up several times last night     True  False 
 
5. I felt tired after waking up this morning    True  False 
 
6. I feel that I didn't get enough sleep last night   True  False 
 
7. I got up in the middle of the night     True  False 
 
8. I felt rested after waking up this morning    True  False 
 
9. I feel that I only had a couple of hours' sleep last night  True  False 
 
10. I feel that I slept well last night     True  False 
 
11. I didn't sleep a wink last night     True  False 
 
12. I didn't have trouble falling asleep last night   True  False 
 
13. After I woke up last night, I had trouble falling asleep again True  False 
 
14. I tossed and turned all night last night    True  False 
 
15. I didn't get more than 5 hours' sleep last night   True  False 
 
(Scoring) 
All items are scored true / false 
The first question does not count for the total score 
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One point if answer is 'true': questions 2, 3, 4, 5, 6, 7, 9, 11, 13, 14, 15 
One point if answer is 'false': questions 8, 10, 12 
Maximum score 14 points, indicating poor sleep the night before 
 
General Study Questionnaire 
Name Date 
 
Do you consider yourself to be a highly endurance 
trained individual? 
(Circle one)                   YES                         NO 
Were you born at an altitude above 1000m (3300ft)? (Circle one)                   YES                         NO 
Have you ever lived at an altitude of 1500m (5000ft) 
or higher for more than 3 months in your lifetime? 
(Circle one)                   YES                         NO 
Have you visited an altitude of 1500m (5000ft) or 
higher anytime in the last 90 days? 
(Circle one)                   YES                         NO 
  
 
Participant Signature Date 
 
 
Modified Physical Activity Readiness Questionnaire (PAR-Q) 
Name Date 
DOB Age Home Phone Work Phone 
Regular exercise is associated with many health benefits, yet any change of activity may increase the risk of 
injury. Please read each question carefully and answer every question honestly: 
Yes No 1. Has your doctor ever said that you have a heart condition and that you should only do physical activity recommended by a doctor? 
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Yes No 2. Do you feel pain in your chest when you do physical activity? 
Yes No 3. In the past month, have you had chest pain when you were not doing physical activity? 
Yes No 4. Do you lose your balance because of dizziness or do you ever lose consciousness? 
Yes No 5. Do you have a bone or joint problem that could be made worse by a change in your physical activity? 
Yes No 6. Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or heart condition? 
Yes No 7. Do you know of any other reason you should not do physical activity? 
Yes No 8. Has your doctor ever told you that you have diabetes?  
Yes No 9. Has your doctor ever told you that you have high blood pressure?  
Yes No 10. Has your doctor ever told you that you have high cholesterol?  
Yes No 11. Has your doctor ever told you that you have high blood sugar?  
Yes No 12. Do you smoke? 
Yes No 13. Are you currently inactive?  
Yes No 
14. Do you have a father, brother or son with heart disease before the age of 55 years 
old or a mother, sister or daughter with heart disease before the age of 65 years 
old? 
15. Measure height and weight to determine BMI:        16. Measure resting BP and pulse 
Height:________                                                                 BP:_______________  Pulse:____________ 
Weight:________                                                           
 
Participant Signature Date 
 
Note to ParQ Reader: 
 
The following guidelines will be used for exclusion criteria for this study: 
A “yes” to any Question except #13 will eliminate the individual from participation. 
#15: If over 25 kg/m2, the individual will be excluded from participation. 
#16:  If resting systolic BP > 140mmHg or resting diastolic BP > 90mmHg, the individual will be 
excluded from participation. 
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Appendix C 
INDIANA UNIVERSITY INFORMED CONSENT STATEMENT FOR 
 
Time to arrive at altitude and short-term pre-acclimatization strategies for competitions at moderate altitude 
 
You are invited to participate in a research study that will help determine the effects of different 
exposure times to simulated altitude and the effects on cycle exercise performance, sleep quality, 
and blood measures.  You were selected as a possible subject because you identified that you were a 
highly endurance trained individual.  We ask that you read this form and ask any questions you may 
have before agreeing to be in the study.  
 
Disclaimer:  It is possible that you will not qualify for the study following the completion of the 
breathing function test or completion of the maximal exercise test. 
 
The study is being conducted by Robert F. Chapman, Ph.D. (Principal Investigator) and Josh Foss in 
the Department of Kinesiology at Indiana University-Bloomington.   
 
STUDY PURPOSE 
 
The purpose of the proposed study is to investigate the influence of either 2 hours or 14 hours of 
exposure to a simulated altitude on exercise performance, sleep quality, and blood measures.  We will 
be examining how your responses to these two simulated altitude conditions compare to each other, as 
well as compared to normal exposure to room air. 
 
NUMBER OF PEOPLE TAKING PART IN THE STUDY: 
 
If you agree to participate, you will be one of 20 subjects who will be participating in this research. 
 
PROCEDURES FOR THE STUDY: 
 
If you agree to be in the study, the following items are included: 
 
An invitation will be extended to visit the Human Performance laboratory a total of 5 times.  Each 
visit will be done at a previously agreed-upon time.  The first two visits last about 75 minutes and the 
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remaining three visits last about 15 hours, which includes an overnight sleep in the lab.  You should 
refrain from exhaustive exercise (exercise that causes significant fatigue) for 24 hours prior to each 
visit.  
 
Visit #1 
This visit includes the following tests: a) measures of your height, weight, resting pulse, and resting 
blood pressure, b) a breathing function test, and c) a maximal exercise test on a cycle ergometer (a 
stationary bicycle). This visit will last approximately 75 minutes.  
 
Visit #2  
This visit includes a 20 km (12.4 mile) time trial on a stationary bicycle.  This visit will last 
approximately 75 minutes. 
 
Visits #3 through #5 
These visits to the lab involve:  a) two tests to measure the amount of hemoglobin in your body,  b) 
12 hours resting in an 8 ft x 8 ft x 6 ft plastic enclosure (which includes a bed for sleeping),  c) 
completing a questionnaire,  d) 2 hours of resting either in the plastic enclosure or wearing a face 
mask connected to breathing tubes, and e) a 20 km time trial on a stationary bicycle.  During these 
visits, the air you breathe will either be room air (with a normal oxygen content) or air with a reduced 
oxygen content, similar to what you would experience in the mountains at an altitude of 8,000 ft.  
These visits will last approximately 15 hours, which includes time you can sleep. 
 
Each of these tests are described below. 
 
Height, weight, and blood pressure measures.  Height will be measured by asking you to stand 
against a wall and a device will be lowered until it touches the top of your head.  Weight will be 
measured by having you sit on a chair, which is placed on a scale.  Blood pressure will be measured 
by placing a cuff around your upper arm.  The cuff will be inflated, squeezing your upper arm, then 
quickly deflated.  A tester will listen to blood moving through your arm using a stethoscope.  Your 
pulse will be measured by a tester who will place his / her fingers on your arm near your wrist, 
pressing slightly for about 15 seconds.  
 
Breathing Function Tests.  Tests of breathing function are performed as described by the American 
Thoracic Society.  These tests include the measurement of total lung capacity (the volume of air your 
lungs can hold), vital capacity (the volume of air you can push out with one maximal breath), FEV1 
(the volume of air you can forcefully breathe out in one second), and maximal voluntary ventilation 
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(the maximal volume of air you can breathe in 12 seconds).  For all of these procedures, you wear 
nose clips and breathe through either a disposable or a rubber mouthpiece.  Rubber mouthpieces 
and nose clips are cleansed in a detergent and antibacterial solution following each use.  The 
breathing function tests are performed seated in the same body position as you will be completing 
the exercise test.  These procedures will require approximately 15 minutes total. 
 
Cycle Exercise Tests. 
 
Maximal Exercise Test (visit #1 only).  This exercise test will be completed on a stationary bicycle.  
Resting measurements will be collected for 5 minutes and followed by a 5 minute warm-up at a pace 
you select.  The test begins with cycling at between 70 - 100 rpm with a light resistance load.  Every 2 
minutes, a small amount of additional resistance will be added until you can no longer maintain the 
required power output.  The goal is for you to exercise for as long as you can. 
 
20 km Time Trial (visits #2 through 5).  This exercise test will be completed on a stationary bicycle.  
For this test, you will be instructed on how to manually change the resistance setting on the bicycle.  
Resting measurements will be collected for 5 minutes and followed by a 10 minute warm-up at a light 
intensity.  When the test begins, your goal is to complete a distance of 20 km (12.4 miles) in as short 
of a time as possible.  For most trained men, this distance takes between 30 and 50 minutes to cycle.  
You can manually adjust the resistance and pedal at whatever pace you choose.  You will be able to 
view a screen that shows the distance completed, the time elapsed, your pedal revolutions per 
minute, and your power output.  For two of these tests, the air that you breathe will have a reduced 
oxygen content, similar to what you would experience in the mountains at an altitude of 8,000 ft.  In 
one of the tests, you will breathe room air with a normal oxygen content.  At regular intervals, we will 
ask you to rate how hard your legs are working and how much effort it takes to breathe.  We will 
have a chart for you to point to, to indicate your selection. 
 
Each of the cycle exercise tests includes wearing a wireless heart rate monitor strap and breathing 
through a face mask which covers your nose and mouth.  Air will flow into and out of your lungs as 
you breathe through the face mask. The face mask and heart rate monitor are cleansed in a 
detergent and antibacterial solution following each use.   During each cycle exercise test, a fiber optic 
cable will be placed on your index finger or your ear lobe.  This device uses light waves to measure 
the oxygen levels in your blood. 
 
Overnight Altitude Tent Exposure:  You will be asked to arrive at the lab at approximately 6pm after 
eating dinner.  After measuring your weight, you will be asked to enter a commercially available 
altitude tent, commonly used by athletes to simulate an altitude environment at sea level.  The tent 
is a canopy measuring 8ft x 8ft x 6ft with plastic walls and a zipper opening and is placed over the top 
of a standard full size inflatable air mattress for sleeping.   
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In one of the three overnights, you will breathe low oxygen air (equivalent to an altitude of 8,000ft) 
for 14 hours.  In a second test, you will breathe room air for 12 hours and low oxygen air (equivalent 
to an altitude of 8,000ft) for 2 hours.  In a third test, you will breathe room air for 14 hours.  While in 
the tent, you will be asked to wear a fiber optic cable on your index finger, which uses light waves to 
measure the oxygen levels in your blood as well as your heart rate.  You will also be asked wear an 
activity monitor on your wrist, which fits like a wristwatch, to monitor the quality of your sleep. 
 
While in the tent, you will have access to food and drink.  If you need to urinate while in the tent, we 
will have a hand held plastic bottle for you to use, so that we can measure your urine output.  Should 
you need to defecate during your time in the tent, we have a face mask you can wear attached to 
hoses and a bag of air to breathe.  You can then leave the tent and walk approximately 50 feet to the 
restroom.  You will be free to engage in quiet activities in the tent, including things like reading, video 
watching, internet, etc., but we will ask you to prepare as you normally would in the evening prior to 
a competition.  Fans will be placed in the tent to help control your comfort, and a standard set of 
bedding / pillows will be available.  You may also bring your own bedding if you desire. 
 
You will be woken up if not awake two hours prior to the scheduled start of the 20 km time trial (14 
hours after entering the tent).  You will be asked to bring your own breakfast foods and drinks, and 
you will be asked to eat the same morning meal prior to each time trial.  Beginning two hours before 
the time trial, you will have the option of remaining in the tent, or you can go on a face mask if you 
desire to leave the tent to complete your pre-competition routine.  
 
Total hemoglobin measures.  This test measures the amount of hemoglobin in your blood.  The test 
begins with you immersing your hand in a bucket of warm water for 5 minutes, after which a sterile 
needle will be used to prick your finger and a small blood sample (less than 1/16 of a teaspoon) will 
be collected.  Then, you will be asked to wear nose clips, blow all the air out of your lungs, place a 
mouthpiece in your mouth, then breathe air in and out from a small bag for two minutes.  The bag 
contains pure oxygen with a small amount of carbon monoxide added.  At the end of two minutes of 
breathing air from the bag, you will be asked to remove the mouthpiece, breathe room air, and place 
your hand back in the bucket of warm water.  After two and four minutes of breathing room air, we 
will pick your finger and obtain a small blood sample (therefore, a total of three finger pricks).  You 
can choose which finger is pricked and if we use the same finger each time or rotate fingers.  
 
This test will be performed twice each on Days #3, #4, and #5.  The first test will occur upon arrival to 
the lab in the evening, just prior to entering the altitude tent.  The second test will occur after 
conclusion of the 20 km time trial the following morning.   
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Sleep Quality Questionnaire:  Upon waking on Days #3, #4, and #5, you will be asked to complete a 
15 question survey.  This questionnaire should take 5 minutes to complete. 
 
RISKS OF TAKING PART IN THE STUDY: 
 
While on the study, the risks are: 
 
A slight risk of headache, temporary light-headedness, throat dryness or fainting exists with 
breathing function testing.  As you will be sitting comfortably and carefully monitored, fainting is not 
likely to occur.  You are free to indicate any discomfort and discontinue participation at any time.  
 
Both maximal and moderate level exercise tests of healthy individuals, as described by the American 
College of Sports Medicine, presents little risk to the subject and does not require medical clearance 
for subjects under 40.  Potential risks and/or discomforts can include episodes of temporary light-
headedness, chest discomfort, leg cramps, occasional irregular heartbeats, and abnormal blood 
pressure responses.  The risk of heart attack, although minor, (approximately 1 to 2 in 10,000) does 
exist.  During the test you will be closely monitored for any abnormal changes in heart rate or 
breathing.  You are free to indicate any discomfort and discontinue participation at any time. 
 
There is a slight risk of skin discomfort or irritation from the fiber optic bundles that will be placed on 
your skin.  
 
There is a risk of blood pooling in your legs and low blood pressure immediately following the cycle 
exercise tests.  After the cycle exercise tests, you will be allowed to cool down on the exercise bike.  If 
at any time during testing you become light headed, you may have to lie down until you feel normal. 
 
Risks associated with taking blood include excessive bleeding, fainting or feeling lightheaded, and 
possible infection.  All blood samples will be taken by qualified individuals.  A reasonable effort will 
be made to minimize the risks associated with drawing blood through the use of proper procedures 
and sterile techniques.   
 
Breathing low oxygen air involves the risk of lightheadedness, rapid breathing, and dry throat.  
Sleeping in an altitude tent may involve poorer quality of sleep, headache, nausea, and frequent 
urination. 
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Breathing carbon monoxide gas can reduce the levels of oxygen in the blood, however, the dose used 
in this study is 10 time lower than the dose required to induce life threatening symptoms.  The 
syringe used to deliver the carbon monoxide gas is not capable of holding an amount necessary to 
cause the oxygen content of your blood to fall significantly. 
 
All face masks, nose clips, and mouth pieces will be cleaned in detergent and antibacterial solution 
after each use, minimizing the risk of virus transmission between subjects. 
 
There is a potential risk of loss of confidentiality.  Note that the restroom available for subject use is 
located  approximately 50 feet down a public hallway from the lab.  While in the hallway, we cannot 
guarantee confidentiality. 
 
BENEFITS OF TAKING PART IN THE STUDY: 
 
The benefits to participation that are reasonable to expect are information regarding breathing function, 
overall level of fitness, and how your performance changes when you go to altitude.  Other than this 
information, you will gain little benefit.  All subjects will be provided with feedback concerning their 
own results and the general findings of the study upon request. 
 
CONFIDENTIALITY 
 
Efforts will be made to keep your personal information confidential.  Data will be stored on password 
protected computers in locked rooms with limited public access.  We cannot guarantee absolute 
confidentiality.  Your personal information may be disclosed if required by law.  Your identity will be 
held in confidence in reports in which the study may be published and databases in which results 
may be stored. 
 
Organizations that may inspect and/or copy your research records for quality assurance and data 
analysis include groups such as the study investigator and his/her research associates, the IU 
Institutional Review Board or its designees, and (as allowed by law) state or federal agencies, 
specifically the Office for Human Research Protections (OHRP) who may need to access the collected 
medical and/or research data. 
 
PAYMENT 
 
You will be paid a total of $100 for completing all (5) days of testing.  Payment will be made by check 
and will be delivered by postal mail within approximately 4 weeks of your final testing session.  If you 
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withdraw prior to completing all days of testing or do not qualify for further participation after Day 1 
of testing, you will be paid according the trial(s) you complete or attempt to complete; $20/trial.   
 
COMPENSATION FOR INJURY 
 
In the event of physical injury resulting from your participation in this research, necessary medical 
treatment will be provided to you at your own expense.  Costs not covered by your health care 
insurer will be your responsibility.  Also, it is your responsibility to determine the extent of your 
health care coverage.  There is no program in place for other monetary compensation for such 
injuries.  However, by signing this form you are not giving up any legal rights or benefits to which you 
are otherwise entitled. 
 
CONTACTS FOR QUESTIONS OR PROBLEMS 
 
For questions about the study or a research-related injury, contact the researcher Robert Chapman, 
Ph.D. at (812) 856-2452 or rfchapma@indiana.edu.  If you cannot reach the researcher during regular 
business hours (i.e. 8:00AM-5:00PM), please call the IU Human Subjects Office at (812) 856-4242 or 
(800) 696-2949.   
 
For questions about your rights as a research participant or to discuss problems, complaints or 
concerns about a research study, or to obtain information, or offer input, contact the IU Human 
Subjects Office at (812) 856-4242 or (800) 696-2949. 
 
VOLUNTARY NATURE OF STUDY 
 
Taking part in this study is voluntary.  You may choose not to take part or may leave the study at any 
time.  Leaving the study will not result in any penalty or loss of benefits to which you are entitled.  
Your decision whether or not to participate in this study will not affect your current or future relations 
with the investigators or Indiana University. 
 
Your participation may be terminated by the investigator without regard to your consent in the 
following circumstances: blood pressure, height and weight, breathing function test, or maximal 
exercise test results that do not meet the criteria for inclusion in the study, an abnormal response to 
exercise, or an inability to complete the exercise tests.  If you leave the study or are removed from the 
study by an investigator, all data collected to that point will still be included in the study files and data 
analysis for the study. 
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SUBJECT’S CONSENT 
 
In consideration of all of the above, I give my consent to participate in this research study.   
 
I will be given a copy of this informed consent document to keep for my records.  I agree to take part 
in this study. 
 
 
Subject’s Printed Name:________________________________________________ 
 
Subject’s Signature:__________________________________Date:  
 (must be dated by the subject) 
 
 
 
Printed Name of Person Obtaining Consent:  
 
Signature of Person Obtaining Consent:                             Date:                 
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